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Reduced synaptic plasticity and excitatory synapse density contribute to 
age-related cognitive decline, and constrain recovery of function from injury in 
adults. A parallel reduction in circulating sex hormones in both sexes, particularly 
estrogens, exacerbates this decline in synaptic plasticity. Conversely, estrogen 
therapy in aged members of many species restores synapse density, promotes 
synaptic plasticity, and improves learning/memory. Importantly, acute estrogen 
administration can promote rapid synaptogenesis, and these new synapses can 
be stabilized by activity. 
 
 
Here I ask if estrogen treatment can promote synaptic plasticity in the 
primary visual cortex (V1) of aged rats. I demonstrate robust expression of 
estrogen receptors (ERs) in V1 of adult male and female rats, suggesting an 
opportunity to enhance plasticity with estrogens. I test this hypothesis following 
the induction of amblyopia by chronic monocular deprivation (cMD). I show that 
cMD reduces thalamic innervation from the deprived eye, and increases 
molecular markers which constrain plasticity, consistent with observations that 
the deficits induced by cMD are highly resistant to reversal. Surprisingly, cMD did 
not change markers for excitatory synapses, suggesting a homeostatic increase 
in synapses serving the non-deprived eye (NDE) to maintain synaptic density 
within an optimal range. Importantly, visually-evoked potentials (VEPs) induced 
by repetitive visual stimulation to the deprived eye depress more rapidly than 
those of the NDE, consistent with cMD inducing an increase in the probability of 
neurotransmitter release (Pr) at synapses in the cMD pathway. 
 
In contrast, treatment of cMD adults with a single dose of 17α estradiol 
significantly increased markers for excitatory synapses, and estradiol treatment 
followed by visual stimulation also increased markers for excitatory synapse 
activity. Repetitive estradiol treatments increased excitatory synapse markers, 
but not synaptic activity markers. Furthermore, one dose of estradiol enhanced 
VEP amplitude following repetitive visual stimulation, however this was observed 
only in response to stimulation of the NDE. As presynaptic ERs are known to 
increase Pr at glutamatergic synapses, this suggests that the effects of estradiol 
 
are specific to spared synapses where Pr has not been up-regulated by 
deprivation. Exploiting this selectivity may allow for receptive field remapping of 
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Chapter 1 : Introduction 
 
1.1 Neural consequences of aging 
 
Our world population is increasing in age (W. He et al., 2016) and age-
related cognitive decline is a progressively significant issue (Gauthier et al., 
2006). Cognitive decline that is independent of other disease, is strongly 
correlated with a global idiopathic shrinking and thinning of the cerebral cortex 
(Du et al., 2007; Pacheco et al., 2015; Singh et al., 2006). The decrease in brain 
matter and cognitive function over time is observed during normal aging in 
healthy individuals. For example, high resolution MRI reveals a significant 
reduction in total surface area, cortical thickness, and intracortical volume in both 
cerebral hemispheres in older participants (mean age = 76.6) relative to younger 
and middle-aged subjects (mean age = 22.8, mean age = 48.6, 
respectively)(Salat et al., 2004). Decreased brain volume and thickness have 
been correlated with reduced performance in a variety of cognitive tasks, 
including tasks that assess episodic, explicit, and working memory (Gunning-
Dixon & Raz, 2003; Head et al., 2008; Raz et al., 1998). The effect of cortical 
atrophy with age is also observed in non-human primate studies, with a gross 
reduction in the thickness of cortical and subcortical areas correlated with 
reduced cognitive performance (Picq et al., 2012).  
 
 Counterintuitively, the gross reduction of cortical mass and cognitive task 
performance during normal aging does not appear to result from a loss of 
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neuronal density, as several reports demonstrate that neuron number is 
preserved with age in humans and non-human primates (Gunning-Dixon & Raz, 
2003; J. H. Morrison & Hof, 1997). Instead, the reduction in cortical mass and 
cognition is correlated with a reduction in synaptic density, specifically excitatory 
synapses on dendritic spines, and a reduction of activity-dependent plasticity at 
these synapses (Bailey et al., 2011; J. H. J. Morrison & Baxter, 2012; Young et 
al., 2014).   
 
The loss of dendritic spines with age is well-documented, and as spines 
are the site of the majority of excitatory synaptic connections in the CNS (Bourne 
Figure 1: Localization of synaptic proteins at excitatory synapses.   
Left: Spine structures distributed on the apical and basolateral dendrites of a primary 
cortical neuron. Cortico-cortical connections express the presynaptic protein VGlut1+ 
(green) and thalamocortical connections express the presynaptic protein VGlut2+ 
(magenta). Right: A magnified representation of the excitatory spiny synapse 
surrounded by the dashed box. In the post synaptic compartment, post-synaptic 
density scaffold protein PSD95 (yellow), is essential for synapse organization and 
present in most excitatory cortical synapses. Phosphorylation of Serine-831 residue on 
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& Harris, 2008), this reduction is predicted to significantly compromise cortical 
function (Peters, Morrison, Rosene, & Hyman, 1998; Peters, Sethares, & Luebke, 
2008) (Fig.1). In non-human primates, a significant reduction in dendritic spines 
was revealed in dye-filled primary neurons across the prefrontal and temporal 
cortices, which correlated with a reduction in performance of cognitive tasks 
(Duan et al., 2003; D. Dumitriu et al., 2010). Similarly, a strong negative 
correlation has been demonstrated in rodents between age and dendritic spine 
density in the prefrontal cortex (Bloss et al., 2011; Nunzi et al., 1987).  
 
Dendritic spines are also important substrates for synaptic plasticity and 
learning, as changes in dendritic spine number and/or size have been repeatedly 
correlated with changes in synaptic strength (Cane et al., 2014; Hotulainen & 
Hoogenraad, 2010; Kasai et al., 2010). In addition, the size of the spine head is 
highly correlated with the size of the postsynaptic density (PSD), a collection of 
scaffolding proteins, such as PSD95 (McAllister, 2007), neurotransmitter 
receptors and signaling molecules that comprise the post-synaptic active zone 
(Harris et al., 1992). At excitatory synapses, the size of the PSD is highly 
correlated with  the number of synaptic AMPA subtype of glutamate receptor, the 
primary ionotropic glutamate receptor in the mammalian CNS, and therefore 
highly correlated with synaptic strength (Nusser et al., 1998; Song & Huganir, 
2002). Dendritic spines can receive excitatory input from thalamic or cortical 
axons, which can be distinguished by the expression of distinct vesicular 
glutamate transporters, VGlut2 in thalamic axons and VGlut1 in cortical axons  
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(VGlut1, VGlut2) (Liguz-Lecznar & Skangiel-Kramska, 2007b). Individual spiny 
synapses can express long-term potentiation (LTP), an activity-dependent 
increase in synaptic strength resulting from coincident activity and thought to be 
the neural correlate of memory (Bliss & Cooke, 2011; S. F. Cooke & Bliss, 2006). 
Furthermore, photolysis of caged glutamate reveals that an enlargement of 
dendritic spine volume is associated with LTP at single spines (Matsuzaki et al., 
2004). Thus, dendritic spine size and PSD size correlate with the strength of 
excitatory synapses, and have been used effectively to track changes in synaptic 
strength (Khan et al., 2013; Kim et al., 2007; Q. Sun & Turrigiano, 2011; Zhang & 
Lisman, 2012) 
   
1.3 Interaction of loss of hormones with aging 
 
The loss of spine synapses with normal aging is widely thought to be 
exacerbated by the developmental decline in circulating sex hormones. In 
humans, age-related cognitive decline has long been associated with a decrease 
in circulating sex hormones (Muller et al., 2005; Yaffe et al., 2000, 2002). In fact, 
induction of menopause through surgical methods, either by hysterectomy or 
oophorectomy in premenopausal women, causes accelerated cognitive decline 
(Bove et al., 2014).  In non-human primates, aged ovariectomized (OVX) animals 
performed poorly in delayed match-to-sample (DNMS) tasks compared to 
younger cohorts (P. R. Rapp et al., 2003). In rodents, an age-related decrease in 
estrogen levels is correlated with a decrease in the number of glutamatergic 
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synapses (Hao et al., 2006). OVX aged rodents show cognitive impairment 
compared to sham-operated subjects (Savonenko & Markowska, 2003). 
Furthermore, OVX aged non-human primates have significantly reduced dendritic 
spine density in PFC compared to young OVX animals (Hao et al., 2006; J. H. J. 
Morrison & Baxter, 2012; Tang et al., 2004). Primary neurons in the aged rat 
hippocampus have reduced apical and basal dendritic spine density in 
comparison to young OVX subjects (Gould et al., 1990). Similarly, inhibition of 
estrogen biosynthesis, via inhibition of aromatase, acutely induces spine synapse 
loss (Zhou et al., 2010). Furthermore, age-related decline in cognitive tasks and 
dendritic spine density are reversed by estrogen treatment in OVX females 
(Bailey et al., 2011; Dumitriu et al., 2010; Hara et al., 2016). Taken together, the 
‘one-two’ punch of aging combined with reduction in sex hormones induces 
significant decrease in synaptic density, plasticity, and cognitive performance.  
 
1.4 Reintroduction of estrogen promotes plasticity  
 
A large body of work demonstrates that reintroduction of sex hormones, 
specifically estrogen, improves cognition. Estrogen therapy (ET) in 
oophorectomized premenopausal women helps to prevent age-related cognitive 
impairment and improves verbal memory (Sherwin, 2012). In addition, ET 
reduces the development of all-cause dementia if initiated by age 65 (Henderson 
et al., 2007). Initiation of ET in early post-menopause improves global cognition, 
attention, and concentration (MacLennan et al., 2006), prevents cognitive decline 
in normally-aging adults (Bagger et al., 2005), and has been proposed to prevent 
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the development of Alzheimer’s disease (Zandi, 2002). Furthermore, ET in post-
menopausal women attenuated the progression of cognitive decline in subjects 
with mild cognitive decline (Yoon et al., 2018). These studies support 
foundational work demonstrating that cognitive task performance peaks during 
periods of high circulating estrogens in premenopausal women (Bailey et al., 
2011).  
 
In aged rhesus macaques, estrogen replacement following OVX improves 
cognitive performance (P. R. Rapp et al., 2003). Following ET, OVX subjects 
acquired cognitive tasks more quickly and performed tasks with more accuracy. 
Additionally, estrogen replacement in OVX rats improved object/place recognition 
and enhanced spatial working memory (Gibbs, 1999; Jacome et al., 2010). 
Estrogen also reduces the severity score and improves water maze performance 
of rodents following traumatic brain injury (Lu et al., 2018). Estrogen 
administered immediately before task learning and/or testing also improved 
performance in social learning, social recognition, object recognition and object 
placement in adult OVX rodents (Luine et al., 2003; Phan et al., 2012). 
Interestingly, estrogen administered immediately after a task improved object 
recognition and memory consolidation (Gresack & Frick, 2006). 
 
These effects of estrogen are thought to be due to estrogen-dependent 
rejuvenation of synaptic function, structure, and excitability to levels that promote 
plasticity. Cyclic fluctuations of estrogen alter dendritic spine density and synaptic 
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potentiation in the hippocampus and cortex (Chen et al., 2009; Gould et al., 
1990; Warren et al., 1995; Woolley & McEwen, 1993). ET in adult rodents has 
been shown to increase the probability of neurotransmitter release at excitatory 
synapses, enhance synaptic strength, and promote synaptic plasticity (Huang & 
Woolley, 2012; Khan et al., 2013; Kramár et al., 2013; Rudick et al., 2003; 
Smejkalova & Woolley, 2010). Inhibition of estrogen synthesis also protects 
against seizure and excitotoxicity (Liu et al., 2012). Importantly, estradiol 
administration promotes the formation of new dendritic spines rapidly and non-
genomically, presumably via activation of membrane-bound estrogen receptors 
(ERs) associated with the PSD (Hojo et al., 2008; Srivastava et al., 2010). Newly 
formed dendritic spines are hypothesized to be stabilized and integrated into 
cortical circuits by activity-dependent, modality-dependent stimulation (Kramár et 
al., 2013; Srivastava et al., 2011).  
 
1.5 cMD as a model for loss of function and synapses  
 
Development of interventions to promote the generation of new spines in 
the aged brain requires an experimental system with rigorous temporal and 
spatial control of synaptic activity, as well as experimental tools that allow for the 
tracking excitatory synapses and other aspects of cortical circuitry with high 
resolution. An asymmetry in the visual input across the two eyes, due to cataract, 
strabismus, or anisometropia, causes amblyopia (Fig. 2A) and a significant 
reduction in vision through the weaker eye. Amblyopia affects an estimated 3% 
of the world’s human population and is the most common form of monocular 
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blindness (Webber & Wood, 2005). Deprivation amblyopia, induced by a 
congenital cataract, can be replicated experimentally by chronic monocular 
deprivation (cMD). Initiated at eye opening and persisting until after adolescence 
(cMD from postnatal day 14 (P14) until ~P150 ( He et al., 2007)), cMD reduces 
vision in the deprived eye, and causes multiple deficits in the deprived eye 
pathway, including a significant decrease in the strength and selectivity of 
visually-evoked responses, and a corresponding decrease in dendritic spine 
density in the visual cortical hemisphere dominated (contralateral) by the 
deprived eye (Montey & Quinlan, 2011) (Fig. 2B). The severe amblyopia induced 
by cMD was previously thought to be irreversible beyond an early postnatal 
critical period (Hubel & Wiesel, 1970). However, the Quinlan lab has shown that 
robust plasticity can be reactivated in adulthood by dark exposure (DE) (He, 
Hodos, & Quinlan, 2006; Murase et al., 2017; Bridi et al., 2018). DE followed by 
visual stimulation promotes the recovery from cMD, including visual acuity, 
synaptic strength, and dendritic spine density (Eaton et al., 2016; Montey et al., 







1.7 Significance / Aims 
 
 DE is slow and may be difficult to administer, I was therefore motivated to 
identify potential pathways to enhance plasticity in the aged amblyopic visual 
cortex that can be used as a  
 substitute for, or used in conjunction with, visual deprivation. I hypothesized that 
the potent neuromodulator, estrogen, which has been previously demonstrated to 
rejuvenate spine synapse density lost with age and/or hormone deprivation, 
would induce synaptogenesis at excitatory synapses in cMD visual cortex. 
Figure 2: Dark Exposure + Visual Training induces spinogenesis 
A. Human child with congenital cataract in left eye, which will induce amblyopia 
if left untreated. B. DiI-filled dendritic branches of neurons in binocular region of 
primary visual cortex (V1b) reveal striking difference in number and shape of 
dendritic spine in adult rats that were normally-reared (left) and chronically-
monocularly deprived (right) from P14-P150. C. Following reverse deprivation 
(open closed eye and close open eye), subjects received 10 days of dark 
exposure (DE) followed by visual training. Dendritic spine density on the 
neurons in the deprived hemisphere (right) have recovered dendritic spine 
density to the level of non-deprived visual cortical neurons (left). Scale bar = 
2.5 µm; data from Montey & Quinlan, 2011.  
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Furthermore, this morphological plasticity could be harnessed to drive 
experience-dependent incorporation of newly-formed spiny synapses into 
functional circuits to promote strengthening of deprived eye visual responses (Fig 
3). An estrogen-based method for the recovery of active excitatory synapses in 
the adult V1 would be a novel strategy for the treatment of amblyopia, with the 
potential to be translated to other functional deficits, such as those due to stroke 









Figure 3: Estrogen will stimulate synaptogenesis and increase strength of visual 
responses 
A. Experimental Schematic: I propose that a single administration of estrogen will stimulate 
spinogenesis / synaptogenesis (1) and the new spines / synapses will either be stabilized and 
incorporated into functional circuits with salient visual experience (2b) or eliminated (2a). B. 
Experimental Prediction: Estrogen paired with visual experience will rescue the anatomical 
and visual plasticity deficits inflicted by chronic monocular deprivation (cMD). Estrogen will 
stimulate synaptogenesis and increase strength of visual responses Scale bar: 2.5 µm. 
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Specific Aim 1 
 
 I characterized the anatomical and physiological effects of cMD in rodent 
V1 using viral tracing, immunohistochemistry, and electrophysiology. I used cMD 
to induce a significant asymmetry in the visual experience across the two eyes. I 
employed transneuronal tracers delivered intraocularly to identify the neurons in 
V1 that serve each eye, and examined molecular markers for the density of the 
extracellular matrix (ECM) and the excitability of fast-spiking interneurons (PV) to 
ask if cMD impacts plasticity in V1. I also asked if cMD impacted the number 
and/or size of excitatory synapses in the deprived and non-deprived cortex by 
quantifying the intensity and distribution of the scaffold protein PSD95. I examine 
the effect of cMD on the number and/or size of thalamic and cortical presynaptic 
specializations by quantifying the intensity and distribution of presynaptic 
excitatory neurotransmitter transporters, VGlut1 and VGlut2. I also examined if 
cMD impacted the activity of signaling pathways known to regulate postsynaptic 
glutamate receptor function by measuring the intensity and distribution of the 
glutamate A1 (GluA1) subunit of the α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptor (AMPAR), phosphorylated on residue Serine 
831 (pS831). In collaboration with a physiologist in the Quinlan lab (Dr. Crystal 
Lantz), we examined the amplitude of visually evoked local field potentials 
(VEPs) in response to repetitive visual stimulation, to ask if cMD impacted the 
short-term depression of VEPs. This work identified novel anatomical and 




Specific Aim 2 
 
I used quantitative immunohistochemistry and electrophysiology ask if 
estrogen treatment impacts the anatomical and functional deficits induced by 
cMD. I demonstrate the presence of estrogen receptor (ER) alpha and beta, in 
intact male and female subjects, and confirm that 17αE2 treatment does not 
induce negative peripheral effects. I ask if estrogen treatment alone, or estrogen 
treatment followed by repetitive visual stimulation regulates the density of the 
ECM, the excitability of PVs, the number and/or size of excitatory synapses, 
thalamic and cortical presynaptic specializations, and the activity of postsynaptic 
PKC/CaMKII signaling. Collaboratively, I asked if estrogen treatment impacted 
the long-term stimulus selective response potentiation induced by repetitive 
visual stimulation. This work identified a surprising specificity to the effect of 
estrogen in the amblyopic visual cortex, and is presented in Chapter 3. In 
Chapter 4, I expand on the interpretation of these results, and pose a list of 





Chapter 2 : Further characterization of the anatomical and physiological 
effects of chronic monocular deprivation in the primary visual cortex of 
aged rats 
 
2.1 Abstract  
 
Monocular deprivation is the classical model of receptive field plasticity 
confined to a postnatal critical period. Chronic monocular deprivation (cMD), 
monocular lid suture from before eye opening until adulthood, induces severe 
amblyopia that is highly resistant to reversal in adults, and is a model of the 
visual deficits caused by unilateral cataract. Here I further characterize the 
anatomical and physiological effects of cMD in the binocular region of primary 
visual (V1b) cortex of adult rats. I used trans-neuronal anterograde tracers to 
show that cMD reduces thalamic input from both eyes to V1b, and expands the 
area innervated by the non-deprived eye into the monocular region of primary 
visual cortex (V1m). To ask about the level of plasticity in the deprived and non-
deprived cortex following cMD, I tracked the expression of two markers that have 
been repeatedly correlated with the state of plasticity. The expression of 
parvalbumin (PV) reflects activity in fast-spiking interneurons, which provide 
strong perisomatic inhibition to cortical pyramidal neurons. The lectin Wisteria 
floribunda agglutinin (WFA) binds to a major component of the extracellular 
matrix (ECM), the maturation which of imposes constraints on anatomical 
plasticity. Following cMD, there is an increase in PV and WFA staining in V1b of 
both cortical hemispheres, consistent with reduced plasticity in the aged 
amblyopic cortex. Quantitative immunohistochemistry revealed no difference in 
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the density of excitatory synaptic markers in the deprived versus non-deprived 
V1b, suggesting that synapses lost by cMD may be counter-balanced by an 
increase in synapses serving the non-deprived. Importantly, visual responses 
evoked by repetitive stimulation of the deprived eye depressed more rapidly than 
responses of the non-deprived eye, suggesting the cMD increases the probability 
of neurotransmitter release synapses serving the deprived eye.  
2.2 Introduction 
 
The plasticity of ocular dominance (OD) of neurons in the binocular region 
of primary visual cortex (V1b) is one of the best studied models of receptive field 
plasticity confined to a postnatal critical period (T N Wiesel & Hubel, 1965; 
Torsten N Wiesel & Hubel, 1963). Neurons in V1b in rodent have a strong 
preference for stimulation from the contralateral eye (contralateral bias), as 
approximately twice as many thalamic afferents to cortex serve the contralateral 
than ipsilateral eye (Coleman et al., 2009). When a unilateral deficit is induced by 
monocular deprivation of the dominant, contralateral eye, there is a shift in the 
ocular preference of binocular neurons away from the contralateral / deprived 
eye and towards the ipsilateral / non-deprived eye. The shift in ocular preference 
induced by monocular deprivation is due in part to a reduction in the number of 
thalamic afferents serving the deprived eye (Hubel et al., 1976; Shatz & Stryker, 
1978). If the monocular deprivation is initiated at eye opening and maintained 
into adulthood (chronic monocular deprivation (cMD)), the physiological, 
anatomical, and acuity deficits in the deprived eye pathway are highly resistant to 
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reversal ( He et al., 2007). These deficits are observed at the anatomical, 
physiological and psychophysical level and include a significant reduction in the 
strength and selectivity of visually responses evoked in the deprived eye, a 
significant reduction in the number of dendritic spines in V1b contralateral to the 
deprived eye, and a significant reduction in spatial acuity of the deprived eye 
(Montey & Quinlan, 2011) .  
 
It is well known that the development of the visual system depends on 
visual experience, and can be significantly attenuated by dark rearing (Kirkwood 
et al., 1995; Mower et al., 1981).  Dark rearing from birth prevents many aspects 
of visual system maturation, such as the refinement of cortical receptive fields, 
the neuronal selectivity for ocular preference and other aspects of visual stimuli, 
visual acuity and maturation of gamma-aminobutyric acid (GABA)-ergic inhibitory 
circuits (M Fagiolini et al., 1994; Morales et al., 2002; Mower, 1991; Regal et al., 
1976).  In addition, dark rearing attenuates developmental changes in the N-
methyl-D-aspartate (NMDA) subtype of glutamate receptors (NMDARs), the 
ionotropic glutamate receptor that is central to Hebbian plasticity mechanisms 
due to dual activation requirements (ligand and voltage) and permeability to 
calcium. In V1, NMDARs at birth are comprised of NR2B and NR1 subunits, and 
have slow kinetics and high sensitivity to agonists (Monyer et al., 1994).  
Evidence suggests that these properties may promote synaptic potentiation after 
NMDAR activation (Paoletti et al., 2013). During the first 5 postnatal weeks of 
development, there is a progressive reduction in NR2b-containing NMDARs and 
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progressive inclusion of the NR2A-containing NMDARs, which increases kinetics 
and decreases calcium permeability (Vicini et al., 1998). Reports indicate that 
these properties may reduce synaptic potentiation after NMDAR activation. Dark-
rearing from birth prevents the switch in NMDAR composition and the 
developmental reduction in the expression of synaptic potentiation (Quinlan et 
al., 1999).  
 
 Surprisingly dark exposure (DE) in adults can also enhance plasticity in 
the visual cortex. DE increases the number of NR2B-containing NMDARs in V1b 
and lowers the threshold for synaptic potentiation (Bridi et al., 2018;  He et al., 
2006). In addition, DE rejuvenates endocannabinoid-dependent long-term 
depression of inhibitory transmission, and extends the window for integration of 
spike-timing dependent plasticity (Guo et al., 2012; S. Huang et al., 2010, 2015). 
These mechanisms lead to a re-expression of critical period-like plasticity, and 
can promote reversal of anatomical and physiological deficits induced by cMD 
(He et al., 2007; Montey & Quinlan, 2011). When DE is followed by visual 
training, such as repetitive performance in a visual discrimination task, deprived 
eye acuity levels fully recover (Montey et al., 2013).  
 
Ongoing work is beginning to reveal the mechanisms for re-expression of 
plasticity following DE. DE followed by light re-exposure (LRx) degrades the 
perisynaptic extracellular matrix (ECM), and is an obligatory step in the 
reactivation of structural and functional plasticity by DE (Murase et al., 2017). 
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Maturation of the ECM has long been known to constrain structural and 
functional plasticity in adult circuits. Reduction in perineuronal nets (PNNs) a 
dense specialization of ECM that ensconce mature parvalbumin+ (PV+) 
interneurons has been repeatedly correlated with enhanced plasticity (Balmer, 
2016). Accordingly, proteolysis of PNNs using an exogenous enzyme 
(chondroitinase ABC (ChABC)) reactivates ocular dominance plasticity in adult 
rodents (Pizzorusso et al., 2002). In amblyopic rodents, the reactivation of 
plasticity by repetitive chABC treatment promotes the recovery of ocular 
dominance of visually-evoked potentials and visual acuity (Pizzorusso et al., 
2006).  
 
DE is not the only method being explored to enhance plasticity in the adult 
visual cortex. Pharmacological or genetic suppression of cortical inhibition can 
cause re-expression of plasticity in adults (Bochner et al., 2014; Gu et al., 2016; 
Morishita et al., 2010), consistent with evidence that  maturation of inhibition 
regulates the timing of the critical period (Michela Fagiolini & Hensch, 2000; 
Takao K Hensch, 2005; Iwai et al., 2003). In addition, environmental enrichment, 
which encourages behavioral and sensorimotor exploration, enhances plasticity 
in adult V1b (Bartoletti et al., 2004; Greifzu et al., 2014; Kalogeraki et al., 2017).  
Amblyopic rats that receive reverse suture (RS, opening of the deprived eye, 
closure of the non-deprived eye) followed by environmental enrichment, have 
basal levels of inhibitory neurotransmitter GABA reduced by a factor of 3 in 
contralateral V1b. Electrophysiological and behavioral measures of visual acuity 
 
 19 
in the deprived eye also improve to the level of the non-deprived eye, and 
contralateral bias is restored (Sale et al., 2007). 
 
In addition, blockade of paired immunoglobulin-like receptor B (PirB), 
which binds major histocompatibility complex I (MHCI) in neurons and recruits 
phosphatases that may restrict neuronal responses to activity-dependent and 
Ca2+ signaling, (Syken et al., 2006) reinstates plasticity in adults (Bochner et al., 
2014). Genetic deletion of PirB reinstates OD plasticity in mice well past the 
critical period (postnatal day 70-74, P70-74) promoting a significant open-eye 
expansion in response to brief MD. Similarly, blockade of the native PirB receptor 
with a soluble ectodomain in wild type adults leads to a comparable expansion of 
the open eye representation following MD. Receptor blockade and eye opening 
reversed deficits in chronically monocularly deprived animals and increased 
spine density in deprived V1, increased deprived-eye VEP amplitudes, and 
significantly improved visual acuity of the deprived eye.  
 
Finally, enhancement of cholinergic transmission in V1 has been shown to 
reverse the deficits of cMD. Genetic deletion of the molecule Lynx1, which binds 
to nAChRs and reduces their affinity for acetylcholine, reactivates robust ocular 
dominance plasticity in response to brief MD (Morishita et al., 2010). In turn, 
Lynx1 knockouts experienced spontaneous reversal of cMD (spanning the length 
of the critical period) by merely opening the deprived eye. When cholinergic 
transmission was enhanced in WTs by a cholinesterase inhibitor, a similar 
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spontaneous reversal of cMD was observed (assessed as recovery of high 
spatial acuity). Lynx1 is localized on PV+ cells in V1, leading to the hypothesis 
that blockade of the Lynx1-nAChR interaction disinhibits pyramidal neurons in 
V1. 
 
Thus, various MD paradigms have been used to investigate experience-
dependent plasticity in a spatially and temporally-controlled manner, as well as 
well as the mechanisms of loss / recovery of neuronal anatomy and physiological 
function. Importantly, most other labs perform MD that is initiated ~P21, allowing 
for one week of binocular vision before MD. In contrast, the Quinlan lab initiates 
MD at eye opening and continuing to adulthood. However, there has been little 
characterization of this form of cMD at the molecular level, which I proposed was 
essential for understanding barriers to recovery and developing further 
interventions for reversal of the deficit.  
 
2.3 Identification and validation of tools employed in this thesis to track 
synaptic density and plasticity  
 
To quantify the number and size of excitatory synapses, I will track 
PSD95, a major component of mature excitatory post-synaptic densities. PSD95 
is one of the earliest detectable proteins at the postsynaptic density in nascent 
synaptic connections (McAllister, 2007). PSD95 co-localizes several critical 
synaptic proteins, including neurotransmitter (NT) receptors, as well as 
cytoskeletal elements which organize and create the structure of the synapse, 
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and is thought to enable aspects of spine synapse maturation and LTP induction 
/ expression (Chen et al., 2011; Sheng & Kim, 2011).  The majority of dendritic 
spine synapses contain PSD95 (El-Husseini et al., 2000) and PSD95 
accumulation has been shown to be essential for the stabilization and 
maintenance of spines (Cane et al., 2014). Importantly, spine enlargement is 
correlated with the enlargement of PSD95 immunoreactive area (Ehrlich et al., 
2007). Therefore, PSD95 puncta number and can be used as a correlate for 
excitatory synaptic number and strength. 
 
 Thalamic axons and cortical axons both make excitatory synapses onto 
pyramidal neurons in V1. Vesicular glutamate transporter 1 (VGlut1) is present in 
cortical axons, and vesicular glutamate transporter 2 (VGlut2) is present in in 
thalamocortical axons (Liguz-Lecznar & Skangiel-Kramska, 2007a). Consistent 
with known innervation patterns of cortical and thalamic projections, VGlut1 
labels terminals in all layers of the cortex, while VGlut2 labeling is heavy in 
thalamo-recipient layers (Layers I,  IV, and VI) (Lei et al., 2013). I will use VGlut1 
and VGlut2 to track excitatory synapses in rodent V1 made by cortical and 
thalamic afferents. 
 
 In addition to markers for excitatory synapses, it would be useful to have a 
marker for synaptic activity. Traditionally, immunohistochemistry (IHC) for 
activity-dependent immediate early genes such as c-Fos has been used to track 
the activation of neurons within circuits (Bullitt, 1990). However, immediate early 
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genes label the nucleus and peri-nuclear cytoplasm of recently active neurons, 
and cannot resolve which synapses on these neurons were recently stimulated. 
The same limitations exist for recently developed methods for the activity of 
neurons in real time in vivo, such as GCamP, which is biased toward the strong 
calcium increase seen in the cell body, and back-propagating action potentials in 
the dendrites (Chen et al., 2012; Tian et al., 2009). Alternatively, phosphorylation 
/ dephosphorylation of synaptic proteins by signaling cascades following synaptic 
activation has the potential to report activity of single synapses. The α-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid subtype of glutamate receptor 
(AMPAR), comprised of GluR1/GluR2 or GluR2/GluR3 heterodimers, mediate 
the majority of fast-glutamatergic transmission in the brain (Anggono & Huganir, 
2012). They are highly mobile proteins that undergo constitutive and activity-
dependent trafficking and increases in the number / changes subunit composition 
mediate LTP and LTD (Malenka & Bear, 2004)  Synaptic activity and resulting 
calcium influx results induces Ca2+/calmodulin dependent kinase II (CaMKII) / 
Protein Kinase C (PKC)-dependent phosphorylation of the Serine 831 residue of 
the GluR1 subunit (pS831),  which regulates AMPAR trafficking (Barria et al., 
1997). Importantly, rapid and transient phosphorylation of S831 is induced by 
salient stimulation, with an onset of less than 30 minutes and persistence for ~2 
hours (Whitlock et al., 2006). Thus, phosphorylation of S831-GluR1 reflects 
recent synaptic CaMKII/PKC activity (Ferrario et al., 2011; Whitlock et al., 2006), 
I will therefore use antibody that recognizes the GluR1 subunit of AMPAR only if 




 The experience-dependent maturation of GABAergic inhibition has been 
strongly implicated in the initiation and closure of critical period plasticity 
(Fagiolini & Hensch, 2000; Hensch, 2005; Iwai et al., 2003).  According to this 
model, a threshold level of inhibition is necessary to initiate the critical period, 
and further maturation of inhibitory circuits terminates the critical period. The 
Quinlan lab recently used manipulations of the neurotrophin NRG1/ erbB 
receptor tyrosine kinase signaling pathway, which controls the strength of 
excitation onto fast spiking interneurons (FS INs), to reversibly regulate ocular 
dominance plasticity. NRG1 increases the excitability of FS INs, but the impact of 
this increase depends on the initial state of excitatory input: NRG1 application 
during the critical period induced precocious closure, while blockade of NRG1 
signaling in adults reactivated the critical period for ocular dominance plasticity 
(Gu et al., 2016). Similarly, pharmacological enhancement of inhibition at the 
initiation of MD with diazepam, a positive allosteric modulator of GABAARs, 
blocks OD plasticity during the critical period. Conversely, pharmacogenetic 
reduction of PV interneuron output with Gi-DREADD induces robust OD plasticity 
in adults (Kuhlman et al., 2013).  
 
Importantly, inhibitory basket cells, which make up of the majority of 
interneurons in the cortex,  express the calcium-binding protein parvalbumin (PV) 
(Whissell et al., 2015). PVs have fast-spiking dynamics and innervate the cell 
bodies of pyramidal neurons (Freund & Katona, 2007). Mature PV+ basket cells 
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are ensconced in thick extracellular matrix specialization known as perineuronal 
nets (PNNs), which may electrochemically sequester synapses around the soma, 
(Carstens et al., 2016) and provide binding sites for molecules that maintain the 
excitability of PV+ interneurons (Balmer, 2016).  PNNs can be visualized with 
wisteria floribunda (WFA), a plant lectin that binds a N-acetyl-D-galactosamine 
side chain of the chondroitin sulfate proteoglycans (CSPGs), a major component 
of the ECM (Miyata & Kitagawa, 2016). Both the maturation of PV circuitry and 
the PNNs have been correlated with reduced synaptic plasticity (Balmer, 2016; 
Harauzov et al., 2010; Lensjø et al., 2017). Therefore, I will use PV 
immunoreactivity and WFA staining as two ways to assess the potential for 
synaptic plasticity in V1 circuits.  
 
 The shift in ocular dominance following brief MD has been shown to 
reduce the input from the deprived thalamus to the cortex (Fagiolini et al., 1994; 
Gordon & Stryker, 1996; Gu et al., 2013; Maffei et al., 2004). To quantify the 
effect of cMD on thalamic-innervation of the cortex, I will use intraocular injection 
of the H129 strain of herpes simplex virus 1 (HSV-H129), an anterograde, trans-
neuronal viral neuronal tracer that can be engineered to express different 
fluorophores (N. Sun et al., 1996). H129 expressing either EGFP or mCherry will 
be injected intraocularly into each eye, trans-neuronal anterograde transport will 
label neurons in the primary visual cortex are innervated by each eye. I will use 
HSV-H129 to ask how cMD impacts of the representation of the deprived and 




 cMD is also known to induce significant changes in the physiological 
response properties of neurons in V1b. In addition to the decrease in the strength 
and selectivity of visual responses evoked through deprived eye stimulation, I 
hypothesize that cMD may regulate presynaptic function, including a 
compensatory increase in presynaptic release probability. Previous reports have 
shown that brief deprivation induces an increase in release probability of 
excitatory neurons onto excitatory neurons in response to deprived-eye 
stimulation in the visual thalamus and in response to dark rearing in the visual 
cortex (Krahe & Guido, 2011; Yashiro et al., 2005).  These experiments were a 
collaboration with Dr. Crystal L. Lantz, a postdoc in the Quinlan lab with expertise 
in cortical electrophysiological recordings. We will examine changes in the 
amplitude of the VEP during repetitive visual stimulation, which reflects the initial 
release probability, in response to stimulation of the deprived and non-deprived 
eye. Together, the work described in this chapter will characterize the anatomical 
and functional consequences of cMD in the deprived and non-deprived V1. 
 




Long Evans Rats (strain 006, RRID:RGD_2308852) were purchased from 
Charles River Laboratories (Raleigh, NC). Equal numbers of adult (>postnatal 
day 180, >P180) males and females were used. Animals were raised in 12/12 
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hour light/dark cycle and all experiments were performed, or subjects were 
sacrificed, 6 hours into the light phase. All procedures conformed to the 
guidelines of the University of Maryland Institutional Animal Care and Use 
Committee and the Guide for the Care and Use of Laboratory Animals of the 




Subjects were anesthetized with ketamine/xylazine (100 mg/10 mg/kg, 
intraperitoneal). The margins of the upper and lower lids of one eye were 
trimmed and sutured together using a 5-0 suture kit with polyglycolic acid (CP 
Medical). Subjects were returned to their home cage after recovery at 37°C for 1-




The following antibodies/dilutions were used: mouse anti-parvalbumin (PV; 
Millipore; RRID:AB_ 2174013, 1:1000); mouse anti-Post Synaptic Density 95kd 
(PSD95; ThermoFisher; RRID: AB_325399, 1:200); rabbit anti-phospho-Serine 
831-GluR1 (pS831; Sigma Aldrich; RRID:AB_1977218, 1:1000), guinea pig anti-
Vesicular Glutamate Transporter 1 (VGlut1; Millipore; RRID:AB_11214451, 
1:1000); guinea pig anti- Vesicular Glutamate Transporter 2 (VGlut2; Millipore; 
RRID:AB_2665454, 1:2000); followed by appropriate secondary antibodies: goat 
anti-rabbit and anti-mouse IgG conjugated to Alexa-488, 546, or 647 (Life 
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Technologies; RRID:AB_143165, RRID:AB_AB_2534118, RRID:AB_2535805, 
1:300).   
 
Reagents   
 
HSV-H129 EGFP (strain 772; University of Pittsburgh Center for Neuroanatomy 
and Neurotropic Viruses (CNNV)) and HSV-H129 mCherry (strain 373; CNNV) 
were diluted 1:1 with diH2O and 3 μl was injected intraocularly (right eye: 
mCherry; left eye: EGFP) for anterograde delivery to primary visual cortex. 
Chondroitin sulfate proteoglycans (CSPGs) were visualized with fluorescein 




Subjects were perfused with phosphate buffered saline (PBS) followed by 4% 
paraformaldehyde (PFA) in PBS. The brain was post-fixed in 4% PFA for 24 
hours followed by 30% sucrose for 48 hours, and cryo-protectant solution (0.58 
M sucrose, 30% (v/v) ethylene glycol, 3 mM sodium azide, 0.64 M sodium 
phosphate, pH 7.4) for 24 hours prior to sectioning. Coronal sections (40 μm) 
were made on a Leica freezing microtome (Model SM 2000R). Sections were 
blocked with 4% normal goat serum (NGS) in PBS for 1 hour. Antibodies were 






Confocal imaging and analysis 
 
Images were acquired on a Zeiss LSM 710 confocal microscope. HSV 
anterograde viral tracer signal was visualized in single z-section images (2.8 mm2 
or 1.4 mm2), acquired with a 5x (Zeiss Plan-neofluar 5x/0.16, NA=0.16) or 10x 
lens (Zeiss Plan-neofluar 10x/0.30, NA=0.30), and a mean intensity profile was 
calculated using FIJI (NIH). The cortical distribution of WFA and PV 
immunoreactivity was determined in a z-stack (9 x 7.5 μm sections) acquired with 
the same 10X lens. Maximal intensity projections (MIPs; 500 μm width, 900 μm 
depth from cortical surface) were used to obtain mean intensity profile in FIJI. For 
PSD95, pS831, VGlut1, and VGlut2 staining, MIPs of z-stacks (40 slices x 0.9 
μm images) were acquired at 100X (Zeiss Plan-neofluar 100x/1.3 Oil DIC, 
NA=1.3). PSD95, pS831, VGlut1, and VGlut2 puncta were selected (PSD95 and 
pS831: 0.02-0.6 μm2, VGlut1 and VGlut2: 0.02-2 μm2) in MIPs (of 28.34 x 28.34 
x 40 μm z-stack images, 550 μm depth from cortical surface) based on 
fluorescence thresholding (autothreshold) in FIJI. Co-localization of pS831, 
PSD95, VGlut1, and VGlut2 was analyzed in single z-section images (28.34 x 
28.34 μm images, 550 μm depth from cortical surface) taken at 100X (Zeiss 
Plan-neofluar 100x/1.3 Oil DIC, NA=1.3), using the JACoP plugin in FIJI (NIH). 
 
Acute In Vivo Recordings 
 
Visually evoked potentials (VEPs) were recorded from the binocular region of 
primary visual cortex (V1b) of adult rats contralateral to the chronically deprived 
eye. Rats were anesthetized with 3% isoflurane in 100% O2 and a 3 mm 
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craniotomy was produced over V1b (centered 3 mm lateral to the midline and 7 
mm posterior from Bregma). A 1.8 mm 16-channel platinum-iridium linear 
electrode array (~112 μm site spacing, 250 kΩ, (Zold & Hussain Shuler, 2015)) 
was inserted perpendicular to V1b (dorsal/ventral, 1.8 mm). Recordings under 
2.5% isoflurane in 100% O2 commenced 30 minutes after electrode insertion. 
Local field potentials were acquired via a RZ5 amplifier (Tucker Davis 
Technology) with a 300 Hz low pass filter and a 60 Hz notch filter. VEPs were 
evoked through passive viewing of repetitive flash stimuli (full field, 28 cd/m2, 
100% contrast, alternating 1Hz (0.5 second white, 0.5 second black), via 
MATLAB (MathWorks) with Psychtoolbox extensions (Brainard, 1997; Pelli, 
1997)). Average VEP waveforms were calculated for the 100 visual presentations 
and were assigned to layers based on waveform shape. VEP amplitude was 
measured from peak to trough of the evoked response in MATLAB, as in 
(Murase et al., 2017) . To examine the short-term plasticity of VEP amplitude, 
each eye was individually presented with full field flash stimulus, alternating 
between black and white every 0.5 seconds. Single trial VEP responses were 
normalized to the first evoked response.  
 
Experimental Design and Statistical Analysis  
 
Primary visual cortex was defined with anatomical landmarks (shape of the 
dorsal hippocampal commissure, deep cerebral white matter tract, and the 
forceps major of the corpus callosum). Modest shrinkage due to fixation and 
cryoprotection reduced vertical depth to 900 μm (Wehrl et al., 2015). Fluorescent 
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puncta were identified using size exclusion parameters defined by unbiased 
quantification for each marker following the construction of a cumulative 
distribution of puncta size, and setting a 10% lower bound and 90% upper bound 
(Cane et al., 2014; Lei et al., 2013). An unpaired two-tailed Student’s T-test was 
used to determine the significance between two independent experimental 
groups, and a paired Student’s T-test was used for two measurements within the 
same subject. One-way ANOVA was used to determine statistical significance 
between three independent groups. Repeated measures ANOVA, with between 
group comparisons, was used to determine the significance of more than two 
measures within the same subjects, followed by a Tukey-Kramer honestly 
significant difference post hoc for pairwise comparisons if p < 0.05 (JASP). A 
Kolmogorov-Smirnov test (K-S Test) was used to determine the significance 
between the distributions of two independent data sets. Multi-dimensional K-S 
Test was used for data sets with two independent measurements (MATLAB). 
Statistical significance (p<0.05) is represented as asterisks in figures, data is 









2.5  Results 
 




To test the hypothesis that cMD (from P14 – P180) reduces deprived-eye 
innervation to the contralateral V1, I injected viral trans-neuronal tracer HSV-
H129 EGFP into the right eye (strain 772) and HSV-H129 mCherry into the left 
eye (strain 373) of an adult binocular control and an adult cMD subjects, allowing 
5 days for the labeling to reach V1. Eye-specific innervation from the thalamus to 
the cortex, revealed by dual intraocular HSV-H129, confirms > 1.5 fold 
innervation of layer 4 from the contralateral than the ipsilateral eye in adult 
binocular controls (Average Fluorescence ±SEM; Ipsi HSV-EGFP 54.61±0.22, 
Contra HSV-mCherry 81.33±0.85; Fig.4B). cMD significantly decreases the 
thalamic innervation from the deprived/contralateral eye, reducing the initial 
contralateral bias (Average Fluorescence ±SEM; Ipsi HSV-EGFP 40.26±0.25, 
Contra HSV-mCherry 47.38±0.22, Fig.4B). cMD also expands the territory 
innervated by the non-deprived / ipsilateral eye into the monocular region of V1 


















Figure 4. Trans-neuronal tracing reveals reduced innervation from deprived eye to V1 
A. Experimental timeline. Subjects receive monocular deprivation from eye opening 
(~postnatal day 14, ~P14) to adulthood (>P180). B.  Left: Confocal double fluorescent 
micrographs of V1b 5 days after delivery of H129 373, mCherry into contralateral and H129 
772, EGFP into ipsilateral eye in a control binocular (top) and a cMD subject (bottom). (ML: 
4mm AP:-6.72 mm DV: 1.5mm; ROI: 2000μm x 2000μm; 5x mag with 0.6x digital zoom; 
900μm x 1000μm; 10x mag with 0.6x digital zoom). Right: Reduced H129 mCherry and EGFP 
in V1b following cMD.  
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2.5.2. Inhibitory interneuron activity and ECM expression increased with 
cMD 
 
To ask if cMD altered the excitability of fast-spiking interneurons (FS INs), 
I examined the effect of visual deprivation on the expression of the calcium-
binding protein parvalbumin (PV), known to be regulated by activity (Donato et 
al., 2013; Murase et al., 2017).  Monocular deprivation from eye opening until 
P180 induced a significant increase in the expression of PV in V1b contralateral 
and ipsilateral to the occluded eye relative to binocular controls (AVG±SEM; 
Binoc 22.54±2.68 vs. Contra cMD 26.18±2.67, p<0.001; Binoc 22.54±2.68 vs. 
Ipsi cMD 25.59±1.42, p<0.001, K-S Test, n=6, Fig.5B). As the activity of FS INs 
is negatively correlated with pyramidal neuron excitability, this high ratio of 
inhibition / excitation, is expected to contribute to the stability of cMD cortex and 
resistance to reversal.  
 
Another powerful negative regulator of synaptic plasticity is the maturation 
of the extracellular matrix (ECM), which is known to constrain plasticity in adult 
circuits (Carulli et al., 2010; Gogolla et al., 2009; Oray et al., 2004; Pfeffer et al., 
2013; Pizzorusso et al., 2002, 2006). Tracking ECM density with WFA (which 
labels N-acetyl-D-galactosamine side chains of the CSPGs, a primary 
component of ECM) in cMD subjects revealed an increase WFA staining in V1b 
contralateral and ipsilateral to the occluded eye compared to binocular controls 
(AVG±SEM; Binoc 15.00±2.00 vs. Contra cMD 16.63±2.08, p<0.001; Binoc 
15.00±2.00  vs. Ipsi cMD 18.23±2.79, p<0.001, K-S Test, n=6, Fig.5C). The 
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increase in CSPG density is also expected to contribute to the stability of cMD 
cortex and resistance to reversal.  
 
 
Figure 5: cMD increases PV and WFA staining in V1b contralateral and ipsilateral to 
cMD 
A. Experimental timeline. Subjects receive monocular deprivation from eye opening (~P14) to 
adulthood (>P180). B. Above: Graphic representations of impact of PV expression on 
pyramidal neuron excitability. Below: Fluorescent micrographs of PV distribution in V1b (red, 
V1; ML: 4 mm AP: -6.72 mm DV: 1.5mm; ROI: 900 μm x 500 μm; 10x mag; MIP). cMD 
significantly increases PV intensity in V1b contralateral and ipsilateral to cMD,*=p<0.01, K-S 
Test, Binoc n=4, cMD n=6. C. Above: Fluorescent micrographs of WFA distribution in V1b 
(green, V1; ML: 4mm AP: -6.72 mm DV: 1.5mm; ROI: 900 μm x 500 μm; 10x mag; MIP). cMD 
significantly increases WFA intensity in V1b contralateral and ipsilateral to cMD, *=p<0.001, K-




2.5.3 Excitatory synapse density is preserved despite cMD  
 
To ask if cMD impacted the number and/or size of excitatory synapses in 
V1b, I quantified the size and numbers of immunoreactive puncta for the scaffold 
protein PSD95. Despite cMD, quantitative immunofluorescence revealed no 
difference in PSD95 puncta number in V1b contralateral or ipsilateral to the 
occluded eye, however, PSD95 puncta size was significantly reduced by cMD 
relative to binocular controls  (Table 1, Fig.6B). 
 
Table 1: PSD95 size / number following cMD 
PSD95 Puncta 
Size 
Average+/- SEM n P value  
Binoc 0.081±0.01 μm2 4 KS test 
Contra cMD  0.080±0.01 μm2 6 *=p<0.001 vs. Binoc 
Ipsi cMD  0.078±0.01 μm2 6 *=p<0.001 vs. Binoc 
PSD95 Puncta # Average+/- SEM n P value 
Binoc 279.58±36.99 4 one-way ANOVA, F(df,15)= 
0.46, p=0.64 
Contra cMD  250.97±29.30 6 Non-Significant (NS), 
p>0.05 

















To ask if cMD impacted the activity of signaling pathways known to 
regulate glutamate receptor function and plasticity, I examined the size and 
number of immunoreactive puncta of the glutamate A1 (GluA1) subunit of the α-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR), 
phosphorylated on residue Serine 831 (pS831). Again, despite cMD, quantitative 
immunofluorescence revealed no difference number, nor in the size of pS831 




Figure 6. Characterization of the anatomical response of excitatory synapses to cMD 
A. Left: Experimental timeline. Subjects receive monocular deprivation from eye opening 
(~P14) to adulthood (>P180). Right: Fluorescent micrograph ROI location in Layer 4 of V1b 
(red box). B. Top: Fluorescent micrographs of PSD95 (yellow) from Binocular Control (Binoc, 
left), Contralateral cMD (Contra cMD, middle), and Ipsilateral cMD (Ipsi cMD, right) V1b (ML: 
4mm AP: -6.72 mm DV: 1.5mm; ~500 μm from surface; ROI: 28.34 μm x 28.34 μm x 40 μm, 
100x mag with 3x digital zoom; maximal intensity projection (MIP)). Bottom: Significant 
decrease in size and no change in number of PSD95 immunoreactive puncta in V1b following 
cMD in contralateral and ipsilateral hemispheres, *=p<0.001, K-S Test, Binoc n=4, cMD n=6. 
C. Top: Fluorescent micrographs of pS831 (green) from Binocular Control (Binoc, left), 
Contralateral cMD (Contra cMD, middle), and Ipsilateral cMD (Ipsi cMD, right) V1b (ML: 4mm 
AP: -6.72 mm DV: 1.5 mm; ~500 μm from surface; ROI: 28.34 μm x 28.34 μm x 40 μm, 100x 
mag with 3x digital zoom; MIP). Bottom: No change in average immunoreactive puncta 
number or cumulative puncta size distribution of pS831, Binoc =4, cMD = 6. D. Top: 
Fluorescent micrographs of VGlut1 (Red) from Binocular Control (Binoc, left), Contralateral 
cMD (Contra cMD, middle), and Ipsilateral cMD (Ipsi cMD, right) V1b (ML: 4mm AP: -6.72 mm 
DV: 1.5mm; ~500 μm from surface; ROI: 28.34 μm x 28.34 μm x 40 μm, 100x mag with 3x 
digital zoom; maximal intensity projection (MIP)). Bottom: No change in average 
immunoreactive puncta number or cumulative puncta size distribution of pS831, Binoc =4, 
cMD = 6. E. Top: Fluorescent micrographs of VGlut2 (magenta) from Binocular Control (Binoc, 
left), Contralateral cMD (Contra cMD, middle), and Ipsilateral cMD (Ipsi cMD, right) V1b (ML: 
4mm AP: -6.72 mm DV: 1.5 mm; ~500 μm from surface; ROI: 28.34 μm x 28.34 μm x 40 μm, 
100x mag with 3x digital zoom; MIP). Bottom: Significant increase in size and no change in 
number of PSD95 immunoreactive puncta in V1b following cMD in contralateral and ipsilateral 
hemispheres, *=p<0.001, K-S Test, Binoc n=4, cMD n=6.  
 
 38 
Table 2: pS831 size / number following cMD 
pS831 Puncta 
Size 
Average+/- SEM n P value  
Binoc 0.075±0.003 μm2 4 KS test 
Contra cMD  0.073±0.002 μm2 6 NS, p>0.05 vs. Binoc 
Ipsi cMD  0.069±0.005 μm2 6 NS, p>0.05 vs. Binoc 
pS831 Puncta # Average+/- SEM n P value 
Binoc 159.98±17.79 4 one-way ANOVA, 
F(df,15)= 0.69, p=0.51 
Contra cMD  234.74±49.94 6 NS, p>0.05 
Ipsi cMD  240.40±64.77 6 NS, p>0.05 
 
To investigate how cMD impacted the distribution of excitatory afferents, I 
examined the number sand size distributions of markers for thalamic axons 
(vesicular glutamate transporter 2 (VGlut2)) and cortical axons (vesicular 
glutamate transporter 1 (VGlut1)). Again, I observed no significant difference in 
the number of VGlut2 puncta in V1b contralateral or ipsilateral to the occluded 
eye, although there was an increase in puncta size (Table 4, Fig.6E). 
Furthermore, there was no significant different in the number or size of VGlut1 







Table 3: VGlut1 size / number following cMD 
VGlut1 Puncta 
Size 
Average+/- SEM n P value  
Binoc 0.17±0.02 μm2 4 KS test 
Contra cMD  0.17±0.02μm2 vs.  6 NS, p>0.05 vs. Binoc 
Ipsi cMD  0.17±0.02μm2  6 NS, p>0.05 vs. Binoc 
VGlut1 Puncta # Average+/- SEM n P value 
Binoc 330.13±47.61 4 one-way ANOVA, 
F(df,15)=0.51, p=0.61 
Contra cMD  348.00±31.03  6 NS, p>0.05 
Ipsi cMD  376.89±28.74  6 NS, p>0.05 
 
Table 4: VGlut2 size / number following cMD 
VGlut2 Puncta 
Size 
Average+/- SEM n P value  
Binoc  0.16±0.01 μm2 4 KS test 
Contra cMD  0.18±0.01 μm2 6 *=p<0.001 vs. Binoc 
Ipsi cMD  0.17±0.02 μm2 6 *=p<0.001 vs. Binoc 
VGlut2 Puncta # Average+/- SEM n P value 
Binoc 330.13±47.61 4 one-way ANOVA, 
F(df,15)=1.46, p=0.26 
Contra cMD  373.69±26.56 6 NS, p>0.05 
Ipsi cMD  287.69±49.28 6 NS, p>0.05 
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To ask if the excitatory synapse markers employed (PSD95, VGlut1 and 
VGlut2, and pS831) reveal competent excitatory synapses, I used Pearson’s 
coefficient analysis to assess colocalization between markers. Pearson’s 
correlation coefficient (PCC) values range from -1 (anti-correlation of two 
populations) to 1 (perfect correlation) and 0 meaning no overlap of two groups 
(Dunn et al., 2011).  In binocular controls, PCC for postsynaptic marker PSD95 
showed high colocalization with presynaptic markers VGlut1 (cortico-cortical 
synapses) and VGlut2 (thalamocortical synapses) (Table 5, Fig.7). Similarly, 
there was high colocalization between pS831 and PSD95 (Table 5, Fig.7) and 
pS831 with VGlut1 and VGlut2 (Table 5, Fig.7). The high PCC values suggest 






Figure 7. Colocalization of excitatory synapse markers 
Left to right: Colocalization analysis using Pearson’s Correlation Coefficient (PCC) of PSD95 / 
pS831, VGlut1 / PSD95, VGlut1 / pS831, VGlut2 / PSD95, and VGlut2 / pS831 of Binocular 
controls reveals high overlap of synaptic markers, n=4. 
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Table 5.: Colocalization of synaptic markers following cMD 
PSD95-VGlut1 
Coloc. 
Average+/- SEM n P value  
Binoc 0.59±0.03 4 one-way ANOVA, F(df,15) 
=0.08, p=0.92 
Contra cMD  0.57±0.04  6 NS, p>0.05 
Ipsi cMD  0.58±0.03 6 NS, p>0.05 
pS831-VGlut1 Coloc. Average+/- SEM n P value 
Binoc 0.46±0.03 4 one-way ANOVA, 
F(df,15)=0.26, p=0.77 
Contra cMD  0.42±0.05  6 NS, p>0.05 
Ipsi cMD  0.45±0.03 6 NS, p>0.05 
PSD95-VGlut2 
Coloc. 
Average+/- SEM n P value 
Binoc 0.56±0.09 4 one-way ANOVA, 
F(df,15)=1.69, p=0.22 
Contra cMD  0.45±0.03  6 NS, p>0.05 
Ipsi cMD  0.45±0.02 6 NS, p>0.05 
pS831-VGlut2 Coloc. Average+/- SEM n P value 
Binoc 0.51±0.06 4 one-way ANOVA, 
F(df,15)=1.46, p=0.26 
Contra cMD  0.37±0.03  6 NS, p>0.05 
Ipsi cMD  0.38±0.03 6 NS, p>0.05 
pS831-PSD95 Coloc. Average+/- SEM n P value 




Contra cMD  0.48±0.02  6 NS, p>0.05 
Ipsi cMD  0.50±0.02 6 NS, p>0.05 
 
However, the PCC of any combination of these excitatory synapse 
markers did not change in either hemisphere of V1b following cMD (Table 5). 
Together, this suggests that although thalamic input from the deprived eye to the 
cortex is reduced by MD, overall excitatory synaptic density and thalamic 
innervation is maintained. This suggests that deprivation-induced reduction in 
synaptic input from deprived eye to the cortex may be counter-balanced by an 
increase in other excitatory synapses, including those serving the non-deprived 
eye.  
 
2.5.4 Accelerated depression of deprived eye visually-evoked responses 
during repetitive visual stimulation  
 
cMD significantly reduces the amplitude of the VEP from the deprived eye 
and reduces the stimulus selectivity of individual V1b neurons (He et al., 2007; 
Montey et al., 2013), however how cMD impacts the biophysical properties 
deprived eye relative to non-deprived eye synapse is unknown. Brief monocular 
deprivation (5-7 days) increase the probability of neurotransmitter release at 
retino-geniculate synapses serving the deprived eye (Krahe & Guido, 2011), a 
homeostatic change that is thought to compensate for reduced activity due to 
deprivation. To ask if cMD impacts the probability of neurotransmitter release, my 
colleague Dr. Crystal L. Lantz examined the amplitude of  visually evoked 
potentials (VEPs) recorded from the binocular region of primary visual cortex 
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(V1b) contralateral to the deprived eye in response to repetitive visual 
stimulation. A microelectrode array was inserted perpendicular to V1b 
(dorsal/ventral, 1.8 mm) and recordings under 2.5% isoflurane commenced 30 
minutes after electrode insertion. To examine the short-term plasticity of VEP 
amplitude, each eye was individually presented with full field flash stimulus (28 
cd/m2) alternating between black and white every 0.5 seconds. Single trial VEP 
responses were normalized to the first evoked response. VEPs were isolated 
from layer 2/3 of V1b contralateral to the occluded eye were acquired in 
response to repetitive flash stimuli (full field, 0.5 second white, 0.5 second black) 
and amplitudes were normalized to the first VEP (Fig. 8B). The depression of 
VEP amplitudes during repetitive stimulation was greater in response to 
stimulation of the deprived / contralateral eye than non-deprived / ipsilateral eye 
(Second VEP response normalized to first, µV, AVG±SEM; Ipsi: 0.59±0.13, 
Contra: 0.29±0.02; Repeated measures ANOVA, p < 0.001, F = 47.683, between 
groups, p = 0.007, F = 15.773, n = 4 subjects, Fig. 8B). The magnitude of 
synaptic depression depends on initial release probability (Regehr, 2012), 
therefore the enhanced depression of the deprived/contralateral eye pathway 







The chronic MD employed here differs from other animal models of MD, in 
that the cMD is initiated at eye opening, prior to the onset of vision. Therefore, 
this cMD prevents early binocular vision and replicates the absence of binocular 
vision in children born with a unilateral congenital cataract. Following cMD there 
is a reduction in thalamic input to the cortex serving the deprived eye. However, 
excitatory synaptic density remains unchanged, suggesting a homeostatic 
plasticity to maintain synaptic activity and density following MD. In addition, 
molecular markers that reflect the state of plasticity in the circuit suggest that 
Figure 7: Rapid depression of VEPs in response to stimulus of deprived 
eye 
A. Experimental timeline. Subjects receive monocular deprivation from eye 
opening (~P14) to adulthood (>P180) then undergo eye opening. VEPs in 
response to repeated 1 Hz flash stimuli are assessed after 24 hours. B. VEP 
amplitudes in response to flash stimuli evoked from ipsilateral (non-deprived, 
red) and contralateral eye (deprived, blue) normalized to amplitude of first 
response.  Contralateral eye VEPs depress more rapidly than ipsilateral eye 
VEPs. *p<0.05, between groups repeated measures ANOVA, n = 4 subjects.  
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plasticity is low in the cMD adult cortex, which is likely to contribute to extreme 
resistance to spontaneous reversal from cMD.  
 
My trans-neuronal tracing with HSV-H129 supports previous observations 
that cMD significantly decreases the thalamic innervation to the cortex from the 
deprived/contralateral eye, which is a strong contributor to the reduction in 
contralateral bias (Montey & Quinlan, 2011; Tagawa et al., 2005).  These 
experiments also reveal a maintenance of connectivity between the deprived eye 
and the visual cortex, despite very prolonged monocular deprivation. This is 
consistent with the observation the visually-evoked potentials and single unit 
activity can be evoked the deprived eye following cMD, however these visual 
responses are weak and un-tuned. The maintenance of anatomical and 
functional connectivity is also likely to be necessary to enable recovery from 
cMD. 
 
Two fundamental characteristics of circuits that impact plasticity include 
the level of excitability of pyramidal neurons and the density of ECM. In both 
cases, an intermediate level is thought to be permissive, to allow spike-timing-
dependent changes in synaptic strength for the former, and to allow synaptic 
expansion / retraction for the latter. cMD resulted in an increase in PV expression 
and an increase in WFA staining, two changes that are predicted to constrain 
plasticity in the adult cortex. It is unlikely that these increases are an initial 
response to MD, as MD induces a rapid decrease in the excitability of FS INs and 
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disinhibition of pyramidal neurons (Kuhlman et al., 2013).  It is more likely that 
the changes represent homeostatic responses to prolonged MD. Importantly, 
change in PV expression and WFA staining are co-regulated. The maturation of 
PV+ interneurons coincides with the development of stable extracellular matrix 
(ECM) and PNNs have binding sites for molecules that regulate AMPAR content 
at excitatory synapses onto PV neurons, like NARP and NRG1 (Gu et al., 2013; 
Gu et al., 2016).  
 
The observation that PSD95 and pS831 immunoreactive puncta are 
unchanged following cMD appears at first to conflict with previous reports that 
cMD induced a significant reduction (50%) in dendritic spine density in deprived 
cortex (Montey & Quinlan, 2011).  One possibility is that following cMD, dendritic 
spines collapse, but PSD structure is maintained. Work performed in pyramidal 
neurons in culture demonstrates a retraction of dendritic spines that is 
independent of a loss of PSD95, and in some cases, spine retraction was 
associated with an increase in PSD95 fluorescence on the dendritic shaft 
(Woods et al., 2011).  
 
The observation that cMD appears to increase the initial probability of 
release at synapses serving the deprived-eye has interesting implications for the 
potential expression of further plasticity at these synapses. The increase in 
release probability would occlude pre-synaptic forms of Hebbian potentiation, 
which may also contribute to the lack of plasticity in cMD adults. This may offer 
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an additional explanation as to why simply opening the deprived eye or giving 
visual experience alone does not induce a recovery of visual acuity. These 
findings provide a foundation for the development of potential interventions to 
reverse the deficits induced by cMD, as well as inform the interpretation of the 









Chapter 3 : The effects of estrogen and visual stimulation on V1 of cMD 
adult rats 
 
3.1 Abstract  
 
Estrogen delivery has been shown to enhance synaptic density and 
plasticity in the hippocampus and prefrontal cortex. Here I test the hypothesis 
that estrogen promotes plasticity in V1 of adult amblyopes, a possibility that is 
supported by the presence of both major estrogen receptor subtypes in V1 of 
adult male and female rodents. Markers for molecular changes that are known 
correlates of cortical plasticity levels, PV expression and WFA staining, are 
decreased following 17αE2 administration. Quantitative immunohistochemistry 
reveals 17αE2 increases the size of PSD95 puncta, a marker for excitatory 
postsynaptic densities in cMD V1, suggesting enhanced anatomical plasticity. 
17αE2 followed by visual stimulation amplifies each of these changes, and 
increases markers for synaptic CaMKII/PKC activity. Importantly, 17αE2 
administration prior to a subthreshold visual stimulation protocol significantly 
enhanced visually-evoked potentials evoked from the non-deprived, but not 
deprived, eye. An increase in release probability of deprived eye synapses is 
predicted following cMD, suggesting that estrogen-induced enhancement of 
plasticity may be limited to synapses with an initial low release probability. Thus, 
the sensitivity to estrogen in adult V1 is determined autonomously by synaptic 






Estrogen is commonly referred to as a female steroid sex hormone, but 
has been demonstrated to play an important role in the both male and female 
physiology across species (Mechoulam et al., 1984; Micevych & Christensen, 
2012; Ozon, 1972; Schulster et al., 2016). Estradiol, the most potent and 
ubiquitous member of the estrogen class, is produced and circulates at high 
levels in mammals, invertebrates, amphibians, fish, and birds (Mechoulam et al., 
1984; Ozon, 1972). In the periphery, 17β estradiol is the predominant form of 
circulating estradiol and is tightly conserved across species (Thornton, 2001). 
17β estradiol is implicated in the regulation of female reproductive cycles, 
development of secondary sex characteristics, development / maintenance of 
reproductive tissues, and mediation of effects in other organs, such as the heart, 
liver, skin and bones (Melmed, 2016). Though 17β estradiol levels in males are 
lower than to females, estradiol is implicated in the regulation of 
spermatogenesis, masculinization of specific brain areas, immune function, and 
cardiovascular health (Carreau et al., 2003; Lombardi et al., 2001; Schulster et 
al., 2016). Importantly, estradiol can be synthesized in the brain and local actions 
of estradiol on neurons has been reported in both males and females (Hara et 
al., 2015; Saldanha et al., 2011).  
 
Estrogen signaling in the brain is mediated by two major receptor 
subtypes: Estrogen Receptor alpha (ERα) and Estrogen Receptor beta (ERβ). 
ERα is present in multiple tissue types, including neuronal, and has high 
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homology across species (Cui et al., 2013; Kumar et al., 2011; Thornton, 2001). 
ERα and ERβ are of similar size (530 versus 495 amino acids), possess similar 
DNA-binding domains (96% homology), ligand-binding domains (56% homology), 
and bind to the same hormone response element on DNA (Weiser et al., 2008). 
ERα and ERβ are expressed throughout the brain and spinal cord and can be 
activated by distinctive, subtype-specific agonists. The mechanistic pathways 
activated by each receptor subtype are varied but overlap (Cui et al., 2013). 
Historically, estrogen-induced effects were thought to be primarily mediated 
through receptors that act on the cell nucleus and mediate transcriptional effects. 
In this case, estradiol crossing the cell membrane binds to cytoplasmic ERα or 
ERβ, induces homo- or heterodimerization and transport of the receptor complex 
into the nucleus, which binds to estrogen response elements (ERE) on DNA to 
regulate transcription (Levin, 2005). However, cell membrane-bound receptors 
also exist, and have been shown to mediate diverse and  rapid effects in the 
brain that are independent of transcription. At excitatory synapses, activation of 
presynaptic ERα / ERβ increases glutamatergic transmission and increases 
mESPC frequency and amplitude, which is thought to promote synaptic 
potentiation (Oberlander & Woolley, 2016; Smejkalova & Woolley, 2010). 
Importantly, an estrogen-induced increase mEPSC frequency has been shown to 
be specific for synapses with low initial probability of release (Smejkalova & 
Woolley, 2010). Postsynaptic ERβ activation can stimulate the formation of 
dendritic spines by activation of  cofilin / actin polymerization (Kramár et al., 
2013) and increase in synapse size via PSD95 translation (Akama & McEwen, 
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2003). At inhibitory synapses, 24 hours of estrogen administration to 
hippocampal neurons in culture activates presynaptic ERα  reduces the strength 
of inhibitory transmission (decreases mIPSCs) and  increases mEPSCs, and 
dendritic spine density (Murphy et al., 1998).  Acute estrogen rapidly reduces 
mIPSC frequency in pyramidal neurons of layer 2/3 V1 in older mice, and an ERα 
antagonist occludes the decrease in mIPSC amplitude observed following dark 
exposure (Gao et al., 2017). Post-synaptic ERα activation in inhibitory neurons 
can suppress GABAergic transmission via retrograde endocannabinoids (G. Z. 
Huang & Woolley, 2012). Furthermore, ERα / ERβ signaling in the inhibitory post-
synaptic compartment can cause destabilization of the scaffold protein gephyrin 
and GABAARs and reduce inhibitory synaptic currents, demonstrated by reduced 
mIPSC amplitudes (Mukherjee et al., 2017).   
 
Each of the above mentioned effects on synaptic function occur rapidly, 
and independently of the regulation of transcription. Estrogen application to 
rodent hippocampal slices increases the magnitude and lowers the threshold for 
LTP in CA3 neurons within 30 minutes in response to theta burst stimulation 
delivered to CA1 (Kramár et al., 2013). This effect is equally robust in 
hippocampal slices from males and females, and is accompanied by an increase 
in the size of PSD95 puncta, suggesting that estrogen induces plasticity in both 
sexes through similar mechanisms. Acute estrogen administered to OVX rats 
induces a rapid (within 30 minutes) and dose-dependent increase in the dendritic 
spines on CA1 neurons in the hippocampus (MacLusky et al., 2005). Estrogen 
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increases NMDAR conductance at excitatory TA-CA1 synapses in hippocampus 
and upregulates the density of immature dendritic spines, which is attenuated by 
blockade of GluN2B‐containing NMDAR (Smith et al., 2016).  In mature, 
mushroom-type spines, estrogen increases the colocalization of PSD95 and the 
GluR2 subunit of the AMPAR (Avila et al., 2017). However, administration of 
estrogen to the dorsal hippocampus increases the density of immature-type 
spines, while temporarily attenuating AMPAR-mediated mEPSCs (Phan et al., 
2015).  
 
Conversely, the decrease in circulating estrogen with age is strongly 
correlated with a decrease in cognitive function and concurrent loss of neuronal 
dendritic spines in humans and animal models (expanded discussion of this work 
was presented in Chapter 1, (Bailey et al., 2011; Dumitriu et al., 2010; P. R. 
Rapp et al., 2003)). Importantly, reintroduction of estrogen through hormone 
replacement therapy improves cognition and increases dendritic spine density to 
the level of younger and non-hormone deprived cohorts in humans, non-human 
primates, and rodents (Bagger et al., 2005; Gibbs, 1999; Hao et al., 2006; Hara 
et al., 2016; Rapp et al., 2003; Savonenko & Markowska, 2003). However, 
estrogen can also have off-target negatives impacts, depending on dosage and 
time course of therapy (Manson et al., 2014). It is therefore imperative that 
potential therapeutic use of estrogen to improve plasticity minimize risk while 




Here, I will test the hypothesis that a low concentration of 17αE2 
enhances plasticity in primary visual cortex of adult amblyopic rodents. For these 
experiments I chose to use 17α-Estradiol (17αE2), a stereoisomer of the main 
circulating estradiol (17β) that is inactive in the reproductive systems of adult 
animals, but induces rapid and potent synaptogenesis in the hippocampus that is 
~2 fold higher in magnitude than an equivalent doses of 17β estradiol (MacLusky 
et al., 2005; Toran-Allerand et al., 2005). 17α has 100-fold lower efficacy for 
nuclear ERs of both subtypes, and a preferential affinity for ERα (Kuiper et al., 
1997). I will administer a single dose of 17αE2 and examine the expression of 
markers for synaptic plasticity and excitatory synaptic density and activity, 
predicting that 17αE2 creates a more permissive environment for anatomical 
plasticity and increases synaptic density. Activity-dependent stimulation has been 
predicted to be essential for the stabilization and incorporation of newly-formed, 
estrogen-induced synapses (Srivastava, 2012; Srivastava et al., 2008).  
Therefore, I will also test the hypothesis that 17αE2 followed by visual stimulus 
will result in a greater increase in synaptic density and activity than 17αE2 alone. 
Collaboratively with Dr. Crystal Lantz, I will examine the effect of 17αE2 
administration to cMD subjects on the expression of activity-dependent plasticity 
of visual responses in the visual cortex, and ask if 17αE2 has similar effect on 
plasticity of synapses serving the deprived and non-deprived eye. Together, 
these results will be the first anatomical and physiological assessment of 
estrogen-induced plasticity in amblyopic rodent visual cortex and will potentially 
inform estrogen-based therapy for sensory deficits. 
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Long Evans Rats (strain 006, RRID:RGD_2308852) were purchased from 
Charles River Laboratories (Raleigh, NC). Equal numbers of adult (>postnatal 
day 180, >P180) males and females were used. Animals were raised in 12/12 
hour light/dark cycle and experiments were performed, or subjects were 
sacrificed, 6 hours into the light phase. All procedures conformed to the 
guidelines of the University of Maryland Institutional Animal Care and Use 
Committee and the Guide for the Care and Use of Laboratory Animals of the 




Subjects were anesthetized with ketamine/xylazine (100 mg/10 mg/kg, 
intraperitoneal). The margins of the upper and lower lids of one eye were 
trimmed and sutured together using a 5-0 suture kit with polyglycolic acid (CP 
Medical). Subjects were returned to their home cage after recovery at 37°C for 1-




The following antibodies/dilutions were used: rabbit anti-estrogen receptor α 
(ERα; ThermoFisher, RRID: AB_325813, 1:1000); mouse anti-estrogen receptor 
β (ERβ; ThermoFisher; RRID:AB_930765, 1:1000); mouse anti-parvalbumin (PV; 
Millipore; RRID:AB_ 2174013, 1:1000); mouse anti-Post Synaptic Density 95kd 
 
 55 
(PSD95; ThermoFisher; RRID: AB_325399, 1:200); rabbit anti-phospho-Serine 
831-GluR1 (pS831; Sigma Aldrich; RRID:AB_1977218, 1:1000), guinea pig anti-
Vesicular Glutamate Transporter 1 (VGlut1; Millipore; RRID:AB_11214451, 
1:1000); guinea pig anti- Vesicular Glutamate Transporter 2 (VGlut2; Millipore; 
RRID:AB_2665454, 1:2000); followed by appropriate secondary antibodies: goat 
anti-rabbit and anti-mouse IgG conjugated to Alexa-488, 546, or 647 (Life 
Technologies; RRID:AB_143165, RRID:AB_AB_2534118, RRID:AB_2535805, 
1:300).   
 
Reagents   
 
4',6-Diamidine-2'-phenylindole dihydrochloride (DAPI, Sigma; 1:10000) was used 
to visualize cell nuclei. Chondroitin sulfate proteoglycans (CSPGs) 
were visualized with fluorescein wisteria floribunda lectin (WFA, Vector Labs; 
1:1000). 17α Estradiol (17αE2; Sigma Aldrich) was diluted to 15 μg/kg in sesame 




A subset of subjects was anesthetized with 2.5% isoflurane in 100% O2 30 
minutes after 17αE2 administration and received visual stimulation by passive 
viewing of 200 x 1 second trials of square-wave gratings (0.05 cycles per degree 
(cpd), 100% contrast, 28 cd/m2, reversing at 1 Hz, via MATLAB (MathWorks) with 






Subjects were perfused with phosphate buffered saline (PBS) followed by 4% 
paraformaldehyde (PFA) in PBS. The brain was post-fixed in 4% PFA for 24 
hours followed by 30% sucrose for 48 hours, and cryo-protectant solution (0.58 
M sucrose, 30% (v/v) ethylene glycol, 3 mM sodium azide, 0.64 M sodium 
phosphate, pH 7.4) for 24 hours prior to sectioning. Coronal sections (40 μm) 
were made on a Leica freezing microtome (Model SM 2000R). Sections were 
blocked with 4% normal goat serum (NGS) in PBS for 1 hour. Antibodies were 
presented in blocking solution for 24 hours, followed by appropriate secondary 
antibodies. 
 
Confocal imaging and analysis 
 
Images were acquired on a Zeiss LSM 710 confocal microscope. Co-localization 
of ERα and ERβ with DAPI was analyzed in single z-sections (70.86 x 70.86 μm 
images, 550 μm depth from cortical surface) taken at 40X (Zeiss Plan-neofluar 
40x/1.3 Oil DIC, NA=1.3), using the JACoP plugin in FIJI (NIH). The cortical 
distribution of WFA and PV immunoreactivity was determined in a z-stack (9 x 
7.5 μm sections) acquired with the same 10X lens. Maximal intensity projections 
(MIPs; 500 μm width, 900 μm depth from cortical surface) were used to obtain 
mean intensity profile in FIJI. For PSD95, pS831, VGlut1, and VGlut2 staining, 
MIPs of z-stacks (40 slices x 0.9 μm images) were acquired at 100X (Zeiss Plan-
neofluar 100x/1.3 Oil DIC, NA=1.3). PSD95, pS831, VGlut1, and VGlut2 puncta 
were selected (PSD95 and pS831: 0.02-0.6 μm2, VGlut1 and VGlut2: 0.02-2 
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μm2) in MIPs (of 28.34 x 28.34 x 40 μm z-stack images, 550 μm depth from 
cortical surface) based on fluorescence thresholding (autothreshold) in FIJI. Co-
localization of pS831, PSD95, VGlut1, and VGlut2 was analyzed in single z-
sections (28.34 x 28.34 μm images, 550 μm depth from cortical surface) taken at 




Acute In Vivo Recordings 
 
Visually evoked potentials (VEPs) were recorded from the binocular region of 
primary visual cortex (V1b) of cMD adult rats contralateral to the chronically 
deprived eye. Rats were anesthetized with 3% isoflurane in 100% O2 and a 3 
mm craniotomy was produced over V1b (centered 3 mm lateral to the midline 
and 7 mm posterior from Bregma). A 1.8 mm 16-channel platinum-iridium linear 
electrode array (~112 μm site spacing, 250 kΩ, (Zold & Hussain Shuler, 2015)) 
was inserted perpendicular to V1b (dorsal/ventral, 1.8 mm). Recordings under 
2.5% isoflurane in 100% O2 commenced 30 minutes after electrode insertion. 
Local field potentials were acquired via a RZ5 amplifier (Tucker Davis 
Technology) with a 3000 Hz low pass filter and a 60 Hz notch filter. VEPs were 
evoked through passive viewing of 100 x 1 second trials of square-wave gratings 
(0.05 cycles per degree (cpd), 100% contrast, reversing at 1 Hz, 28 cd/m2, via 
MATLAB (MathWorks) with Psychtoolbox extensions (Brainard, 1997; Pelli, 
1997). Average VEP waveforms (100 stimuli) were assigned to layers based on 
waveform shape. VEP amplitude was measured from peak to trough of the 
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evoked response in MATLAB, as in (Murase et al., 2017). To examine the short-
term plasticity of VEP amplitude, each eye was individually presented with full 
field flash stimulus, alternating between black and white every 0.5 seconds. 
Single trial VEP responses were normalized to the first evoked response.  
 
Experimental Design and Statistical Analysis  
 
Primary visual cortex was defined with anatomical landmarks (shape of the 
dorsal hippocampal commissure, deep cerebral white matter tract, and the 
forceps major of the corpus callosum). Modest shrinkage due to fixation and 
cryoprotection reduced vertical depth to 900 μm (Montey & Quinlan, 2011; Wehrl 
et al., 2015). Fluorescent puncta were identified using size exclusion parameters 
defined by unbiased quantification for each marker following the construction of a 
cumulative distribution of puncta size, and setting a 10% lower bound and 90% 
upper bound (Cane et al., 2014; Lei et al., 2013). An unpaired two-tailed 
Student’s T-test was used to determine the significance between two 
independent experimental groups, and a paired Student’s T-test was used for 
two measurements within the same subject. One-way ANOVA was used to 
determine statistical significance between three independent groups. Repeated 
measures ANOVA, with between group comparisons, was used to determine the 
significance of more than two measures within the same subjects, followed by a 
Tukey-Kramer honestly significant difference post hoc for pairwise comparisons if 
p < 0.05 (JASP). A Kolmogorov-Smirnov test (K-S Test) was used to determine 
the significance between the distributions of two independent data sets. Multi-
 
 59 
dimensional K-S Test was used for data sets with two independent 
measurements (MATLAB). Statistical significance (p<0.05) is represented as 
asterisks in figures, data is described as mean ± standard error (mean±SEM). 
 
3.4 Results  
 
3.4.1 Robust expression of ERα and ERβ in binocular region of V1 of adult 
male and female rats 
 
To ask if ERs exist in the adult visual cortex, I performed 
immunohistochemistry will well-validated antibodies. Rabbit anti-ERα 
(ThermoFisher, epitope: residues 1-21 of the Activation Function (AF-1) domain 
of the N-terminus (Kumar et al., 2011)) and mouse anti-ERβ (ThermoFisher; 
epitope: residues 467-485 of the Ligand-Binding Domain (LBD) (Kumar et al., 
2011)) reveal robust expression of ERα and ERβ in the adult primary visual 
cortex of male and female Long Evans rats (>P180; Fig.1A).  To ask if ERs are 
present outside the nucleus in adult V1, I compared the distribution of ERα and 
ERβ to the distribution of DAPI (4',6-Diamidine-2'-phenylindole dihydrochloride), 
a fluorescent stain that binds to AT-rich sequences of DNA. Pearson’s correlation 
coefficient reveals very low co-localization between DAPI / ERα and DAPI / ERβ 
in adult V1 (AVG±SEM; DAPI-ERα: Males 0.16±0.005, Females 0.17±0.02; 
DAPI-ERβ: Males 0.12±0.015, Females: 0.14±0.017, n=4; Fig.9B). Staining for 
each of the ER antibodies was lost by pre-absorption with antigen (not shown). 




3.4.2 17α-estradiol administration does not stimulate growth of 
reproductive tissue of gonadally-intact animals 
 
My goal is to examine the effects of estrogen treatment in the aged 
amblyopic V1 using 17α-estradiol (17αE2), an estrogen isomer which is induces 
~2 fold greater synaptogenesis than an equal concentration of 17β-estradiol,  is 
Figure 9. Non-nuclear estrogen receptors in visual cortex of 
male and female adult rats 
A. Single z-section fluorescent micrograph of ERα (top left; 
green) and ERβ (top right; red) immunoreactive puncta in the 
binocular region of primary visual cortex (V1b; ML: 4mm AP :-
6.72 mm DV: 1.5mm; ~500 μm from surface; ROI: 129.17μm x 
129.17μm; 40x mag) in an adult male rat (P189). B. Left: Single 
z-section fluorescent micrographs of triple labeled ERα /ERβ/ 
DAPI (blue) in V1b (ML: 4mm AP :-6.72 mm DV: 1.5mm; ~500 
μm from surface; ROI: 129.17μm x 129.17μm; 40x mag, inset: 
72μm x 82 μm; 40x mag plus 3x digital zoom).  Right: Pearson’s 
correlation coefficient (PCC) reveals equally low correlation 
between DAPI and ERα and ERβ in adult (>P180) males and 
females, n=4.   
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genomically inactive, and reported to not interact with adult reproductive tissue 
(MacLusky et al., 2005; Perusquía & Navarrete, 2005). To confirm the latter, I 
compared gonadal wet weight (normalized to body mass) in treated and 
untreated subjects following repetitive 17αE2 delivery (15 μg/kg, s.c., 1x/day for 7 
days). I observed no significant difference in gonad:body weight ratio after 17αE2 
treatment in female or male subjects (>P180), suggesting that this 17αE2 
treatment did not stimulate gonadal growth (AVG±SEM; female vehicle (veh): 
4.10±0.38 vs. female 17αE2: 5.134±1.09; male veh: 6.01±0.90 vs. male 17αE2: 
5.59±0.34, males n=3, females n=3, Fig 10B). All subsequent experiments 
utilized either a single dose of 17αE2, or the repetitive dose described above (15 
μg/kg, s.c., 1x/day for 7 days).  
Figure 10. 17α estradiol does not enhance gonad 
weight of intact male and female adult rats 
A. Experimental timeline. Adult subjects (>P180) 
receive once-daily 17α-estradiol for 7 days (15 μg/kg, 
s.c. ,1x/day for 7 days). Subjects are sacrificed and 
gonads dissected / weighed. B. No significant 
difference between in gonad / body weight ratio (mg/g) 
in intact male and female subjects which received either 
7 days of vehicle (V) or 7 days of 17α-estradiol (E2), 
n=3 for each group.  
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3.4.3 17αE2 administration increases markers for plasticity in the 
amblyopic visual cortex 
 
 To ask if estrogen treatment induces changes in the cortex that correlate 
with enhanced plasticity, we examined the response to a single dose of 17αE2 
following cMD. We examined the effect of 17αE2 on the expression of the 
activity-dependent calcium-binding protein parvalbumin (PV), a proxy for the 
activity of fast-spiking interneurons (FS INs) (Donato et al., 2013; Murase et al., 
2017).  A single dose of 17αE2 to cMD subjects (15 μg/kg, s.c.) induced a rapid 
(2.5 hour) decrease in the expression of PV in V1b contralateral and ipsilateral 
to the occluded eye (AVG±SEM; Contra cMD 26.18±2.67 vs. Contralateral 
cMD+17αE2 (Contra 17αE2) 24.68±3.61, p<0.001; Ipsi cMD 25.59±1.42 vs. 
Ipsilateral cMD+17αE2 (Ipsi 17αE2) 18.97±3.17, p<0.001, K-S Test, n=6, 
Fig.11B). As the activity of FS INs is negatively correlated with pyramidal neuron 
excitability, this complements previous reports that 17αE2 treatment can 
enhance principal neuron excitability (Córdoba Montoya & Carrer, 1997; Kumar 
& Foster, 2002). Next, I examined the effect of 17αE2 on the density of the 
extracellular matrix (ECM), the maturation of which is known to constrain 
plasticity in adult circuits (Carulli et al., 2010; Gogolla et al., 2009; Oray et al., 
2004; Pfeffer et al., 2013; Pizzorusso et al., 2002, 2006). The ECM is primarily 
composed of chondroitin sulfate proteoglycans (CSPGs), which can be tracked 
by the binding of the lectin Wisteria-floribunda agglutinin (WFA) binding to N-
acetyl-D-galactosamine in chondroitin sulfate sidechains. 17αE2 treatment of 
cMD subjects (15 μg/kg, s.c.) induced a rapid (2.5 hour) decrease in WFA 
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staining in V1b contralateral and ipsilateral to the occluded eye (AVG±SEM; 
Contra cMD 16.63±2.08 vs. Contra 17αE2 14.85±1.82, p<0.001; Ipsi cMD 
18.23±2.79 vs. Ipsi 17αE2 12.62±1.56, p<0.001, K-S Test, n=6, Fig.11C). This 
suggests that a single administration of 17αE2 triggers changes in the adult V1 









3.4.4 17αE2 increases the size of excitatory post-synaptic densities 
 
To ask if 17αE2 treatment impacts the density of excitatory synapses, we 
examined the size and number of PSD95 immunoreactive puncta. 17αE2 
treatment of cMD subjects (15 μg/kg, s.c.) induced a rapid (2.5 hour) and 
significant increase in the size of PSD95 immunoreactive puncta in V1b 
contralateral, but not ipsilateral, to the occluded eye (Contra cMD 0.080±0.01 
μm2 vs. Contra 17αE2 0.082±0.003 μm2, p<0.001; Ipsi cMD 0.078±0.01 μm2 vs. 
Ipsi 17αE2 0.081±0.006 μm2, p=0.55, K-S Test, n=6, Fig.12B), but no change in 
PSD95 number (AVG±SEM; Contra cMD 250.97±29.30 vs. Contra 17αE2 
324.71±47.54; Ipsi cMD 235.60±35.44 vs. Ipsi 17αE2 303.01±25.52, n= 6, 
Fig.12B).   
 
To ask if 17αE2 impacted the activity of signaling pathways known to 
regulate GluA1-AMPAR function and plasticity, I examined the intensity and 
distribution of pS831(Barria et al., 1997; Mammen et al., 1997; Roche et al., 
1996). However, we observed no increase in pS831 puncta size (AVG±SEM; 
Figure 11: 17αE2 reduces PV and WFA staining in V1b contralateral and 
ipsilateral to cMD 
A. Experimental timeline. Subjects receive monocular deprivation from eye opening 
(~P14) to adulthood (>P180) and receive 17αE2 (15 μg/kg, s.c.) 30 minutes prior to 
eye opening. B. Top Left- Fluorescent micrographs of PV distribution in V1b (red, V1; 
ML: 4 mm AP: -6.72 mm DV: 1.5mm; ROI: 900 μm x 500 μm; 10x mag; MIP). Bottom 
Left: Graphic representations of impact of PV expression on pyramidal neuron 
excitability. Right: 17αE2 significantly decreases PV intensity in V1b contralateral and 
ipsilateral to cMD,*=p<0.01, K-S Test, n=6. C. Top Left: Fluorescent micrographs of 
WFA distribution in V1b (green, V1; ML: 4mm AP: -6.72 mm DV: 1.5mm; ROI: 900 μm 
x 500 μm; 10x mag; MIP). Bottom Left: Graphic representations of impact of WFA 
expression on plasticity. Right: 17αE2 significantly decreases WFA intensity in V1b 
contralateral and ipsilateral to cMD, *=p<0.001, K-S Test, n=6.  
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Contra cMD 0.073±0.002 μm2 vs. Contra 17αE2 0.067±0.001 μm2; Ipsi cMD 
0.069±0.005 μm2 vs. Ipsi 17αE2 0.071±0.005 μm2, n=6, Fig.12C) or puncta 
number (Contra cMD 234.74±49.94 vs. Contra 17αE2 273.97±47.53; Ipsi cMD 
240.40±64.77 vs. Ipsi 17αE2 267.99±40.04; n = 6, Fig.12C). This suggests that 
17αE2 may increase the size of pre-existing excitatory synapses consistent via a 

















3.4.5 17αE2 decreases expression of presynaptic markers  
 
To ask if 17αE2 treatment impacts the innervation of V1b after cMD, I 
examined the size and number of puncta that were immunoreactive for the 
cortico-cortical afferent marker VGlut1 and thalamocortical afferent marker 
VGlut2. 17αE2 treatment of cMD subjects induced a significant decrease in the 
size of VGlut1 and VGlut2 immunoreactive puncta in V1b contralateral and 
ipsilateral to the occluded eye (Tables 6-7, Fig.13C). VGlut2 number did not 
change in either hemisphere following 17αE2 (Table 7, Fig.13C), however there 
was a decrease in VGlut1 number in V1b ipsilateral to the occluded eye (Table 6, 
Fig.13B). The decrease in VGlut1 and VGlut2 size following 17αE2 was not 
predicted, as changes in presynaptic size are thought to mirror changes in 
postsynaptic densities (Futai et al., 2007). However, the decrease in the size of 
the presynaptic markers following 17αE2 could be indicative of decreased 
glutamate re-uptake in response to the administration of the hormone, as 
previously reported (Sato et al., 2003).  
 
 
Figure 12. 17αE2 increases size marker for excitatory post-synaptic densities 
A. Experimental timeline. Subjects receive monocular deprivation from eye opening (~P14) to 
adulthood (>P180) and receive 17αE2 (15 μg/kg, s.c.) 30 minutes prior to eye opening.  B. 
Top: Fluorescent micrographs of PSD95 immunoreactivity (yellow) in V1b contralateral (left) 
and ipsilateral (right) to cMD, (ML: 4mm AP: -6.72 mm DV: 1.5mm; ~500 μm from surface; 
ROI: 28.34 μm x 28.34 μm x 40 μm, 100x mag with 3x digital zoom; MIP). Bottom: Cumulative 
distribution of PSD95 immunoreactive puncta size (yellow) reveals significant increase in V1b 
contralateral (left) to the occluded eye, *=p<0.001, K-S Test, n=6.  C. Top: Fluorescent 
micrographs of pS831 immunoreactivity (green) in V1b contralateral (left) and ipsilateral (right) 
to cMD, (V1; ML: 4mm AP: -6.72 mm DV: 1.5mm; ~500 μm from surface; ROI: 28.34 μm x 
28.34 μm x 40 μm, 100x mag with 3x digital zoom; MIP). Bottom: Cumulative distribution of 
pS831 immunoreactive puncta reveals significant decrease in V1b ipsilateral (right) to cMD, K-
S Test, n=6.  
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Table 6: VGlut1 size / number following 17αE2 
VGlut1 Puncta 
Size 
Average+/- SEM n P value  
Contra cMD  0.17±0.02μm2 vs.  6 KS Test 
Contra 17αE2 0.14±0.01μm2 6 *p=<,0.001 vs. Contra cMD 
Ipsi cMD  0.17±0.02μm2  6 KS Test 
Ipsi 17αE2 0.15±0.02 μm2 6 *p=<,0.01 vs. Ipsi cMD 
VGlut1 Puncta # Average+/- SEM n P value 
Contra cMD  348.00±31.03  6 Student’s T-test 
Contra 17αE2 295.36±45.04 6 NS, p>0.05 
Ipsi cMD  376.89±28.74  6 Student’s T-test 






























Average+/- SEM n P value  
Contra cMD  0.18±0.01 μm2 6 *KS Test 
Contra 17αE2 0.13±0.01μm2 6 *p=<,0.001 vs. Contra cMD 
Ipsi cMD  0.17±0.02 μm2 6 KS Test 
Ipsi 17αE2 0.15±0.01μm2 6 *p=<,0.01 vs. Contra cMD 
VGlut2 Puncta # Average+/- SEM n P value 
Contra cMD  373.69±26.56 6 Student’s T-test 
Contra 17αE2 296.22±33.63 6 NS, p>0.05 
Ipsi cMD  287.69±49.28 6 Student’s T-test 
Ipsi 17αE2 351.00±36.49 6 NS, p>0.05 
Figure 13. 17αE2 decreases markers for cortico-cortical and thalamocortical synapses 
A. Left: Experimental timeline. Subjects receive monocular deprivation from eye opening 
(~P14) to adulthood (>P180) and receive 17αE2 (15 μg/kg, s.c.) 30 minutes prior to eye 
opening. Right: Fluorescent micrograph ROI in Layer 4 of V1b (red box). B. Top: Fluorescent 
micrographs of VGlut1 immunoreactivity (red) in V1b contralateral (left) and ipsilateral (right) to 
cMD, (ML: 4mm AP: -6.72 mm DV: 1.5mm; ~500 μm from surface; ROI: 28.34 μm x 28.34 μm 
x 40 μm, 100x mag with 3x digital zoom; MIP). Bottom: Cumulative distribution of VGlut1 
immunoreactive puncta size (red) reveals significant increase in V1b contralateral (left) and 
ipsilateral (right) to the occluded eye, *=p<0.01, K-S Test, n=6. VGlut1 puncta count is 
significantly reduced following 17αE2 in V1b ipsilateral (right) to the occluded eye, *=p<0.05, 
Student’s T-test, n=6. C. Top: Fluorescent micrographs of VGlut2 immunoreactivity (magenta) 
in V1b contralateral (left) and ipsilateral (right) to cMD, (V1; ML: 4mm AP: -6.72 mm DV: 
1.5mm; ~500 μm from surface; ROI: 28.34 μm x 28.34 μm x 40 μm, 100x mag with 3x digital 
zoom; MIP). Bottom: Cumulative distribution of VGlut2 immunoreactive puncta reveals 
significant decrease in V1b contralateral (left) and ipsilateral (right) to cMD, *=p<0.001, K-S 
Test, n=6.  
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3.4.6 17αE2 increases colocalization of pS831 and thalamic afferent 
markers  
 
To ask if 17αE2 treatment changes the co-localization of the markers I use 
to track pre- and postsynaptic compartments, I quantified colocalization of 
postsynaptic marker PSD95, pS831 of GluA1-AMPAR, and presynaptic markers 
VGlut1 and VGlut2. The PCC analysis revealed a significant increase of pS831 
colocalization with VGlut2 in V1b contralateral to the deprived eye (Table 8, 
Fig.14A), and no change in pS831 colocalization with VGlut1 (Table 8, Fig.14B). 
There was also no change in either colocalization of PSD95 with VGlut1 or 
VGlut2, or with pS831 with PSD95 after 17αE2 administration (Table 8). 
Together, this suggests the 17αE2 may increase activity at thalamocortical 
synapses, but does not change the co-localization between markers for pre- and 
postsynaptic contributions to excitatory synapses. 
 
Table 8: Colocalization of synaptic markers following 17αE2  
PSD95-VGlut1 
Coloc. 
Average+/- SEM n P value  
Contra cMD  0.57±0.04  6 Student’s T-test 
Contra 17αE2  0.55±0.03 6 p>0.05 vs. Contra cMD 
Ipsi cMD  0.58±0.03 6 Student’s T-test 
Ipsi 17αE2  0.54±0.05 6 p>0.05 vs. Ipsi cMD 
pS831-VGlut1 
Coloc. 
Average+/- SEM n P value 
Contra cMD  0.42±0.05  6 Student’s T-test 
Contra 17αE2 0.45±0.02 6 p>0.05 vs. Contra cMD 
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Ipsi cMD  0.45±0.03 6 Student’s T-test 
Ipsi 17αE2  0.41±0.06 6 p>0.05 vs. Ipsi cMD 
PSD95-VGlut2 
Coloc. 
Average+/- SEM n P value 
Contra cMD  0.45±0.03  6 Student’s T-test 
Contra 17αE2  0.46±0.04 6 p>0.05 vs. Contra cMD 
Ipsi cMD  0.45±0.02 6 Student’s T-test 
Ipsi 17αE2  0.44±0.03 6 p>0.05 vs. Ipsi cMD 
pS831-VGlut2 
Coloc. 
Average+/- SEM n P value 
Contra cMD  0.37±0.03  6 Student’s T-test 
Contra 17αE2  0.45±0.02  6 *=p<0.05 vs. Contra cMD 
Ipsi cMD  0.38±0.03 6 Student’s T-test 
Ipsi 17αE2  0.42±0.03 6 p>0.05 vs. Ipsi cMD 
pS831-PSD95 
Coloc. 
Average+/- SEM n P value 
Contra cMD  0.48±0.02  6 Student’s T-test 
Contra 17αE2 0.52±0.03 6 p>0.05 vs. Contra cMD 
Ipsi cMD  0.50±0.02 6 Student’s T-test 





3.4.7 17αE2 followed by visual stimulation further decreases markers for 
constrained plasticity in the cMD V1 
 
The response to 17αE2 treatment alone was modest. This was not 
unexpected, as my hypothesis is that newly formed synapses require salient 
stimulation to be incorporated into functional circuits. Therefore, I next examined 
the response to a single dose of 17αE2 followed by visual stimulation in cMD 
subjects. A single dose of 17αE2 to cMD subjects (15 μg/kg, s.c.) was followed 
30 minutes later by a simple visual stimulus known to be sufficient to evoke 
responses from cMD V1 (200 x 1 second trials of square-wave gratings, 0.05 
cycles per degree, 100% contrast, reversing at 1 Hz, at 45 degrees, (Montey & 
Figure 14. Colocalization of pS831 increased at thalamocortical 
synapses 
A. VGlut2-pS831 PCC increased in cMD V1b contralateral to the occluded 
eye following E2, *=p<0.05, Student’s T-test, n= 6. B. No change in 
VGlut1-pS831 PCC in cMD V1b following E2 in contralateral and ipsilateral 
hemispheres, n= 6.  
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Quinlan, 2011)).  17αE2 followed by visual stimulation induced a rapid (2.5 hour) 
decrease in the expression of PV in V1b contralateral and ipsilateral to the 
occluded eye (AVG±SEM; Contra cMD 26.18±2.67 vs. Contralateral 
cMD+17αE2+ Visual Stimulus (Contra 17αE2 Stim) 21.83±2.63, p<0.001; Ipsi 
cMD 25.59±1.42 vs. Ipsilateral cMD+17αE2+Visual Stimulus (Ipsi 17αE2 Stim) 
23.25±2.56, p<0.001, K-S Test, n=6, Fig.15B), which was lower than 17αE2 
alone (AVG±SEM; Contra 17αE2 24.68±3.61vs. Contra 17αE2 Stim 21.83±2.63, 
p<0.001, K-S Test, n=6).   Similarly, 17αE2 followed by visual stimulation induced 
a decrease in WFA expression in V1b contralateral and ipsilateral to the 
occluded eye (AVG±SEM; Contra cMD 16.63±2.08 vs. Contra 17αE2 Stim 
11.77±1.06, p<0.001; Ipsi cMD 18.23±2.79 vs. Ipsi 17αE2 Stim 13.25±1.32, 
p<0.001, K-S Test, n=6, Fig.15C), which was lower than 17αE2 alone 
(AVG±SEM; Contra 17αE2 14.85±1.82 vs. Contra 17αE2 Stim 11.77±1.06, 
p<0.001, K-S Test, n=6). This suggests 17αE2 followed by visual stimulation may 







3.4.8 17αE2 followed by visual stimulation further increases size of  
excitatory synapses and synaptic signaling 
 
To ask if 17αE2 followed by visual stimulation treatment impacts the 
density of excitatory synapses, I revisited markers for the postsynaptic 
specialization. 17αE2 followed by visual stimulation induced a significant 
increase in the size of PSD95 immunoreactive puncta in V1b contralateral and 
ipsilateral to the occluded eye (Contra cMD 0.080±0.01 μm2 vs. Contra 17αE2 
Stim 0.081±0.003 μm2, p<0.001; Ipsi cMD 0.078±0.01 μm2 vs. Ipsi 17αE2 
0.079±0.003 μm2, p<0.05, K-S Test, n=6, Fig.16B), but no change in PSD95 
number (AVG±SEM; Contra cMD 250.97±29.30 vs. Contra 17αE2 306.55±28.97; 
Ipsi cMD 235.60±35.44 vs. Ipsi 17αE2 306.24±31.25, n= 6, Fig.16B).  In addition, 
I observed an increase in pS831 puncta size in V1b contralateral, but not 
ipsilateral, to the occluded eye (AVG±SEM; Contra cMD 0.073±0.002 μm2 vs. 
Contra 17αE2 Stim 0.071±0.003 μm2, p<0.001; Ipsi cMD 0.069±0.005 μm2 vs. 
Ipsi 17αE2 Stim 0.070±0.003 μm2, p=0.07, K-S Test, n=6, Fig.16C), yet no 
change in puncta number (Contra cMD 234.74±49.94 vs. Contra 17αE2 Stim 
Figure 15: 17αE2 followed by visual stimulus reduces PV and WFA staining 
in V1b contralateral and ipsilateral to cMD 
A. Experimental timeline. Subjects receive monocular deprivation from eye 
opening (~P14) to adulthood (>P180) and receive 17αE2 (15 μg/kg, s.c.) 30 
minutes prior to visual stimulus (200 phase reversal of high contrast grating at a 
single orientation). B. Top Left: Fluorescent micrographs of PV distribution in V1b 
(red, V1; ML: 4 mm AP: -6.72 mm DV: 1.5mm; ROI: 900 μm x 500 μm; 10x mag; 
MIP). Bottom Left: Graphic representations of impact of PV expression on 
pyramidal neuron excitability. Right: 17αE2 followed by visual stimulus significantly 
decreases PV intensity in V1b contralateral and ipsilateral to cMD,*=p<0.01, K-S 
Test, n=6. C. Top Left: Fluorescent micrographs of WFA distribution in V1b (green, 
V1; ML: 4mm AP: -6.72 mm DV: 1.5mm; ROI: 900 μm x 500 μm; 10x mag; MIP). 
Bottom Left: Graphic representations of impact of WFA expression on plasticity. 
Right: 17αE2 significantly followed by visual stimulus decreases WFA intensity in 
V1b contralateral and ipsilateral to cMD, *=p<0.001, K-S Test, n=6.  
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274.44±36.20; Ipsi cMD 240.40±64.77 vs. Ipsi 17αE2 Stim 282.15±39.29; n = 6, 
Fig.16C).  This indicates that 17αE2 followed by visual stimulation may induce a 
non-specific increase in the size of excitatory synapses in the aged amblyopic 








3.4.9 17αE2 followed by visual stimulation decreases expression of 
presynaptic markers  
 
To ask if 17αE2 treatment followed by visual stimulus impacts the number 
or size of presynaptic afferents in cMD V1b, I examined the cortico-cortical 
afferent marker VGlut1 and thalamocortical afferent marker VGlut2. Surprisingly, 
17αE2 treatment of cMD subjects followed by visual stimulus induced a 
significant decrease in the size of VGlut2 immunoreactive puncta in V1b 
contralateral and ipsilateral to the occluded eye (AVG±SEM: Contra cMD 
0.18±0.01μm2 vs. Contra 17αE2 Stim 0.13±0.01μm2, p<0.001; Ipsi cMD 
0.17±0.02μm2 vs. Ipsi 17αE2 Stim 0.13±0.02μm2, p<0.001; K-S Test, n=6, 
Fig.17C) and VGlut1 in V1b contralateral to the occluded eye (AVG±SEM: Contra 
cMD 0.17±0.02μm2 vs. Contra 17αE2 Stim 0.14±0.01μm2, p<0.001; Ipsi cMD 
0.17±0.02μm2 vs. Ipsi 17αE2 Stim 0.16±0.02 μm2, p=.55; K-S Test, n=6, 
Fig.17B). VGlut2 number was not changed in either hemisphere following 17αE2 
and visual stimulus (AVG±SEM; Contra cMD 373.69±26.56 vs. Contra 17αE2 
Figure 16. 17αE2 followed by visual stimulus increases markers for excitatory post-
synaptic densities and synaptic activity 
A. Experimental timeline. Subjects receive monocular deprivation from eye opening (~P14) to 
adulthood (>P180) and receive 17αE2 (15 μg/kg, s.c.) 30 minutes prior to visual stimulus (200 
phase reversal of high contrast grating at a single orientation). B. Top: Fluorescent 
micrographs of PSD95 immunoreactivity (yellow) in V1b contralateral (left) and ipsilateral 
(right) to cMD, (ML: 4mm AP: -6.72 mm DV: 1.5mm; ~500 μm from surface; ROI: 28.34 μm x 
28.34 μm x 40 μm, 100x mag with 3x digital zoom; MIP). Bottom: Cumulative distribution of 
PSD95 immunoreactive puncta size (yellow) reveals significant increase in V1b contralateral 
(left) and ipsilateral (right) to the occluded eye, *=p<0.05, K-S Test, n=6. C. Top: Fluorescent 
micrographs of pS831 immunoreactivity (green) in V1b contralateral (left) and ipsilateral (right) 
to cMD, (V1; ML: 4mm AP: -6.72 mm DV: 1.5mm; ~500 μm from surface; ROI: 28.34 μm x 
28.34 μm x 40 μm, 100x mag with 3x digital zoom; MIP). Bottom: Cumulative distribution of 
pS831 immunoreactive puncta reveals significant decrease in V1b contralateral (left) to the 
cMD eye, *=p<0.001, K-S Test, n=6.  
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Stim 375.29±72.36; Ipsi cMD 287.69±49.28 vs. Ipsi 17αE2 Stim 338.18±56.24, 
n= 6, Fig.17C), however there was a decrease in the number of VGlut1 
immunoreactive puncta in V1b contralateral to the occluded eye (AVG±SEM; 
Contra cMD 348.00±31.03 vs. Contra 17αE2 Stim 237.69±25.81; Ipsi cMD 
376.89±28.74 vs. Ipsi 17αE2 Stim 326.69±50.63, p<0.01, Student’s T-test, n= 6, 
Fig.17B). Again, this result was surprising, but consistent with the disconnection 
in PSD95 and VGlut size reported above. As with 17αE2 alone, the observed 
decrease in the size of the presynaptic markers following 17αE2 could be 
indicative of decreased glutamate re-uptake in response to the administration of 


















PCC analysis revealed that 17αE2 plus visual stimulation does not change 
the colocalization of the various markers for excitatory synapses (Table 9).  
 
Table 9: Colocalization of synaptic markers following 17αE2 + Vis Stim 
PSD95-VGlut1 
Coloc. 
Average+/- SEM n P value  
Contra cMD  0.57±0.04  6 Student’s T-test 
Contra 17αE2 Stim 0.61±0.02 6 p>0.05 vs. Contra cMD 
Ipsi cMD  0.58±0.03 6 Student’s T-test 
Ipsi 17αE2 Stim  0.57±0.03 6 p>0.05 vs. Ipsi cMD 
pS831-VGlut1 
Coloc. 
Average+/- SEM n P value 
Contra cMD  0.42±0.05  6 Student’s T-test 
Contra 17αE2 Stim 0.47±0.03 6 p>0.05 vs. Contra cMD 
Ipsi cMD  0.45±0.03 6 Student’s T-test 
Ipsi 17αE2 Stim 0.44±0.06 6 p>0.05 vs. Ipsi cMD 
Figure 17. 17αE2 followed by visual stimulation decreases markers for cortico-cortical 
and thalamocortical afferents 
A. Experimental timeline. Subjects receive monocular deprivation from eye opening (~P14) to 
adulthood (>P180) and receive 17αE2 (15 μg/kg, s.c.) 30 minutes prior to visual stimulus (200 
phase reversal of high contrast grating at a single orientation). B. Top: Fluorescent 
micrographs of VGlut1 immunoreactivity (red) in V1b contralateral (left) and ipsilateral (right) to 
cMD, (ML: 4mm AP: -6.72 mm DV: 1.5mm; ~500 μm from surface; ROI: 28.34 μm x 28.34 μm 
x 40 μm, 100x mag with 3x digital zoom; MIP). Bottom: Cumulative distribution of VGlut1 
immunoreactive puncta size (red) reveals significant increase in V1b contralateral (left) and 
ipsilateral (right) to the occluded eye, *=p<0.01, K-S Test, n=6. VGlut1 puncta count is 
significantly reduced following 17αE2 and visual stimulus in V1b contralateral (left) to the 
occluded eye, *=p<0.05, Student’s T-test, n=6. C. Top: Fluorescent micrographs of VGlut2 
immunoreactivity (magenta) in V1b contralateral (left) and ipsilateral (right) to cMD, (V1; ML: 
4mm AP: -6.72 mm DV: 1.5mm; ~500 μm from surface; ROI: 28.34 μm x 28.34 μm x 40 μm, 
100x mag with 3x digital zoom; MIP). Bottom: Cumulative distribution of VGlut2 
immunoreactive puncta reveals significant decrease in V1b contralateral (left) and ipsilateral 





Average+/- SEM n P value 
Contra cMD  0.45±0.03  6 Student’s T-test 
Contra 17αE2 Stim 0.44±0.03 6 p>0.05 vs. Contra cMD 
Ipsi cMD  0.45±0.02 6 Student’s T-test 
Ipsi 17αE2 Stim 0.48±0.03 6 p>0.05 vs. Ipsi cMD 
pS831-VGlut2 
Coloc. 
Average+/- SEM n P value 
Contra cMD  0.37±0.03  6 Student’s T-test 
Contra 17αE2 Stim 0.42±0.02 6 p>0.05 vs. Contra cMD 
Ipsi cMD  0.38±0.03 6 Student’s T-test 
Ipsi 17αE2 Stim 0.45±0.01 6 p>0.05 vs. Ipsi cMD 
pS831-PSD95 
Coloc. 
Average+/- SEM n P value 
Contra cMD  0.48±0.02  6 Student’s T-test 
Contra 17αE2 0.47±0.03 6 p>0.05 vs. Contra cMD 
Ipsi cMD  0.50±0.02 6 Student’s T-test 
Ipsi 17αE2 Stim  0.45±0.03, 6 p>0.05 vs. Ipsi cMD 
 
 
3.4.10 7 days of 17αE2 administration increases excitatory synapse size 
 
Encouraged by the results with a single dose of 17αE2, I next tested the 
hypothesis that multiple doses of 17αE2 would further promote changes in the 
visual cortex that were permissive for plasticity. Once daily 17αE2 treatment to 
cMD subjects for 7 days (15 μg/kg, s.c., 1x/day), was followed in by visual 
stimulation (as before, 200 x 1 second trials of square-wave gratings (0.05 cycles 
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per degree (cpd), 100% contrast, reversing at 1 Hz) at 45 degrees) 30 minutes 
after the last 17αE2 administration. To ask if 17αE2 followed by visual stimulation 
treatment impacts the density of excitatory synapses, I once more utilized PSD95 
as a marker and examined the number and size of immunoreactive puncta. In 
cMD subjects, both 7 days of 17αE2 treatment and 7 days of 17αE2 treatment 
followed by visual stimulation induced a significant increase in the size of PSD95 
immunoreactive puncta in V1b contralateral and ipsilateral to the occluded eye, 
but no change in PSD95 number (Table 10, Fig.18B). I observed a large increase 
in pS831 puncta size in V1b contralateral and ipsilateral to the occluded eye, but 
a significant decrease in number (Table 11, Fig.18C). This indicates that 7 days 
of 17αE2 with or without visual stimulation induces an increase in the size, but 
not the number, of excitatory synapses in the aged V1 similar to a single dose of 
17αE2 +/- visual stimulation. The reduction in the number of pS831+ puncta, but 
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Table 10: PSD95 size / number following 7d 17αE2 
PSD95 Puncta 
Size 
Average+/- SEM n P value  
Contra cMD  0.080±0.01 μm2 6 KS test 
Contra 7d 17αE2 0.080±0.002 μm2, 8 *=p<0.001 v. Contra MD 
Contra 7d 17αE2 
Stim 
0.075±0.003 μm2 8 *=p<0.001 v. Contra MD 
Ipsi cMD  0.078±0.01 μm2 6 KS test 
Ipsi 7d 17αE2 0.080±0.003 μm2 8 *p<0.05 v. Ipsi MD 
Ipsi 7d 17αE2 Stim  Stim 0.080±0.003 
μm2 
8 *p<0.05 v. Ipsi MD 
PSD95 Puncta # Average+/- SEM n P value 
Contra cMD  250.97±29.30 6 one-way ANOVA, 
F(df,21)=1.03, p=0.37 
Contra 7d 17αE2 187.97±33.31 8 NS, p>0.05 
Contra 7d 17αE2 
Stim 
275.23±46.01 8 NS, p>0.05 
Ipsi cMD  235.60±35.44 6 one-way ANOVA, 
F(df,21)=1.99, p=0.16 
Ipsi 7d 17αE2 195.88±36.83 8 NS, p>0.05 















Figure 18. 7 days of 17αE2 increases markers for excitatory synapses independent of 
pS831 
A. Experimental timeline. Subjects receive monocular deprivation from eye opening (~P14) to 
adulthood (>P180) and 7 days receive 17αE2 (15 μg/kg, s.c., 1x/day for 7 days) and visual 
stimulus (200 phase reversal of high contrast grating at a single orientation) following last day of 
17αE2 treatment. B. Top: Fluorescent micrographs of PSD95 immunoreactivity (yellow) in V1b 
contralateral (left) and ipsilateral (right) to cMD and following 7 days of 17αE2 and 7 days of 
17αE2 followed by visual stimulation, (ML: 4mm AP: -6.72 mm DV: 1.5mm; ~500 μm from surfac  
ROI: 28.34 μm x 28.34 μm x 40 μm, 100x mag with 3x digital zoom; MIP). Bottom: Cumulative 
distribution of PSD95 immunoreactive puncta size (yellow) reveals significant increase in V1b 
contralateral (left) and ipsilateral (right) to the occluded eye following both 7 days of 17αE2 and 7 
days of 17αE2 with visual stimulus, *=p<0.05, K-S Test, n=6, 8, 8, respectively. C. Top: 
Fluorescent micrographs of pS831 immunoreactivity (green) in V1b contralateral (left) and 
ipsilateral (right) to cMD and after 7 days of 17αE2 and 7 days of 17αE2 followed by visual 
stimulation, (V1; ML: 4mm AP: -6.72 mm DV: 1.5mm; ~500 μm from surface; ROI: 28.34 μm x 
28.34 μm x 40 μm, 100x mag with 3x digital zoom; MIP). Bottom: Cumulative distribution of pS83  
immunoreactive puncta reveals significant increase in size V1b contralateral (left) and ipsilateral 
(right) to the cMD eye following both 7 days of 17αE2 and 7 days of 17αE2 with visual stimulus, 
*=p<0.001, K-S Test. pS831 puncta count is significantly reduced following both 7 days 17αE2 
paradigms in V1b contralateral (left) and ipsilateral (right) to the occluded eye. Contralateral V1b  
one-way ANOVA, F(df,21)=6.04, p=0.009, *=p<0.05, Tukey-Kramer post hoc; Ipsilateral V1b: on





Table 11: pS831 size / number following 7d 17αE2 
pS831 Puncta 
Size 
Average+/- SEM n P value  
Contra cMD  0.073±0.002 μm2 6 KS test 
Contra 7d 17αE2 0.097±0.01μm2  8 *=p<0.001 v. Contra MD 
Contra 7d 17αE2 
Stim 
0.074±0.002μm2 8 *=p<0.001 v. Contra MD 
Ipsi cMD  0.069±0.005 μm2 6 KS test 
Ipsi 7d 17αE2 0.097±0.01μm2  8 *p<0.001 v. Ipsi MD 
Ipsi 7d 17αE2 
Stim  
0.072±0.003μm2 8 *p<0.001 v. Ipsi MD 
pS831 Puncta # Average+/- SEM n P value 
Contra cMD  234.74±49.94 6 one-way ANOVA, 
F(df,21)=6.04, p=0.009 
Contra 7d 17αE2 110.53±22.39 8 *=p<0.05 TK post hoc 
Contra 7d 17αE2 
Stim 
106.60±21.36 8 *=p<0.05 TK post hoc 
Ipsi cMD  240.40±64.77 6 one-way ANOVA, 
F(df,21)=4.62, p=0.02 
Ipsi 7d 17αE2 120.89±24.13  8 *=p<0.05 TK post hoc 
Ipsi 7d 17αE2 
Stim  
100.66±20.59 8 *=p<0.05TK post hoc 
 
 89 
3.4.11 7 days of 17αE2 administration downregulates markers for excitatory 
presynaptic terminals  
 
To examine how prolonged 17αE2 treatment, with and without visual 
stimulus, impacts the presynaptic innervation of deprived cMD V1b, I examined 
the size and number  of VGlut1 and VGlut2 immunoreactive puncta. Prolonged 
17αE2 treatment induced a significant decrease in the size of VGlut1 and VGlut2 
immunoreactive puncta in V1b contralateral and ipsilateral to the occluded eye, 
similar to a single dose of 17αE2 (Table 12, Fig 19B; Table 13, Fig 19C, 
respectively). VGlut2 number was reduced in both hemispheres following 7 days 
17αE2 +/- visual stimulation (Table 13, Fig.19C), and VGlut1 number was 
reduced in both hemispheres only in response to 7 day 17αE2 with visual 
stimulus (Table 12, Fig.19B). Again, the increase in postsynaptic size (PSD95 
puncta size) induced by 7 days of 17αE2 in the aged V1 is not matched by an 












Table 12: VGlut1 size / number following 7d 17αE2 
VGlut1 Puncta 
Size 
Average+/- SEM n P value  
Contra cMD  0.17±0.02μm2 vs.  6 KS test 
Contra 7d 17αE2 0.138±0.02μm2 4 *=p<0.001 v. Contra MD 
Contra 7d 17αE2 
Stim 
0.096±0.04μm2 4 *=p<0.001 v. Contra MD 
Ipsi cMD  0.17±0.02μm2  6 KS test 
Ipsi 7d 17αE2 0.13±0.02μm2 4 *p<0.001 v. Ipsi MD 
Ipsi 7d 17αE2 Stim  0.10±0.006μm2 4 *p<0.001 v. Ipsi MD 
VGlut1 Puncta # Average+/- SEM n P value 
Contra cMD  348.00±31.03  6 one-way ANOVA, 
F(df,13)=6.49, p=0.01 
Contra 7d 17αE2 256.92±63.72 4 NS, p>0.05 
Contra 7d 17αE2 
Stim 
176.17±8.23 4 *=p<0.05 TK post hoc 
Ipsi cMD  376.89±28.74  6 one-way ANOVA, 
F(df,13)=5.62, p=0.02 
Ipsi 7d 17αE2 271.33±74.77 4 NS, p>0.05 







Table 13: VGlut2 size / number following 7d 17αE2 
VGlut2 Puncta 
Size 
Average+/- SEM n P value  
Contra cMD  0.18±0.01 μm2 6 KS test 
Contra 7d 17αE2 0.136±0.01μm2,  8 *=p<0.001 v. Contra MD 
Contra 7d 17αE2 
Stim 
0.135±0.02μm2 8 *=p<0.001 v. Contra MD 
Ipsi cMD  0.17±0.02 μm2 6 KS test 
Ipsi 7d 17αE2 0.145±0.01μm2 8 *p<0.001 v. Ipsi MD 
Ipsi 7d 17αE2 Stim  0.15±0.01μm2 8 *p<0.001 v. Ipsi MD 
VGlut2 Puncta # Average+/- SEM n P value 
Contra cMD  373.69±26.56 6 one-way ANOVA, 
F(df,20)=5.07, p=0.02 
Contra 7d 17αE2 161.77±13.55  8 *=p<0.05 TK post hoc 
Contra 7d 17αE2 
Stim 
129.26±10.03 8 *=p<0.05 TK post hoc 
Ipsi cMD  287.69±49.28 6 one-way ANOVA, 
F(df,20)=8.27, p=0.002 
Ipsi 7d 17αE2 174.06±14.15 8 *=p<0.01 TK post hoc 
















3.4.12 7 days of 17αE2 increases colocalization of synaptic markers 
 
To ask if prolonged 17αE2 treatment impacted the co-localization of the 
markers employed to track per- and postsynaptic specializations, I performed 
PCC analysis for marker pairs. The PCC analysis revealed an increase in PSD95 
colocalization with VGlut1 (cortico-cortical marker) in V1b contralateral and 
ipsilateral to the deprived eye after 7 days of 17αE2 with and without visual 
stimulus (Table 14, Fig.20A). Interestingly, the colocalization of pS831 with 
VGlut1 and VGlut2 also increased in V1b contralateral and ipsilateral to deprived 
eye after 7 days of 17αE2 with and without visual stimulus (Table 14, Fig.20B, 
Fig.21B, respectively). However, PSD95 colocalization with VGlut2 and pS831 
colocalization was unchanged in both hemispheres of V1b (Table 13, Fig 21A). 
Figure 19. 7 days of 17αE2 decreases markers for cortico-cortical and thalamocortical 
synapses 
A. Left: Experimental timeline. Subjects receive cMD and 17αE2 (15 μg/kg, s.c., 1x/day for 7 
days) +/- visual stimulus (200 phase reversal of high contrast grating at a single orientation) 
following last day of 17αE2 treatment. Right: Fluorescent micrograph ROI in Layer 4 of V1b 
(red box). B. Top: Fluorescent micrographs of VGlut1 immunoreactivity (red) in V1b 
contralateral (left) and ipsilateral (right) to cMD and following 7 days of 17αE2 and 7 days of 
17αE2 followed by visual stimulation, (ML: 4mm AP: -6.72 mm DV: 1.5mm; ~500 μm from 
surface; ROI: 28.34 μm x 28.34 μm x 40 μm, 100x mag with 3x digital zoom; MIP). Bottom: 
Cumulative distribution of VGlut1 immunoreactive puncta size (red) reveals significant 
increase in V1b contralateral (left) and ipsilateral (right) to the occluded eye following both 7 
days of 17αE2 +/- visual stimulation, *=p<0.01, K-S Test. VGlut1 puncta count is significantly 
reduced following 7 days 17αE2 and visual stimulus in V1b contralateral (left) and ipsilateral 
(right) to the occluded eye. Contralateral V1b: one-way ANOVA, F(df,13)=6.49, p=0.01, 
*=p<0.05, T-K post hoc; Ipsilateral V1b: one-way ANOVA, F(df,13)=5.62, p=0.02, *=p<0.05, T-
K post hoc, n=6, 4, 4, respectively. C. Top: Fluorescent micrographs of VGlut2 
immunoreactivity (magenta) in V1b contralateral (left) and ipsilateral (right) to cMD and after 7 
days of 17αE2+/- visual stimulation, (V1; ML: 4mm AP: -6.72 mm DV: 1.5mm; ~500 μm from 
surface; ROI: 28.34 μm x 28.34 μm x 40 μm, 100x mag with 3x digital zoom; MIP). Bottom: 
Cumulative distribution of VGlut2 immunoreactive puncta reveals significant decrease in V1b 
contralateral (left) and ipsilateral (right) to cMD eye following both 7 days of 17αE2 +/- visual 
stimulation, *=p<0.001, K-S Test. VGlut2 puncta count is significantly reduced following both 7 
days 17αE2 paradigms in V1b contralateral (left) and ipsilateral (right) to the occluded eye. 
Contralateral V1b: one-way ANOVA, F(df,20)=5.07, p=0.02, *=p<0.05, T-K post hoc; 
Ipsilateral V1b: F(df,20)=8.27, p=0.002, *=p<0.01, T-K post hoc, n=6, 8, 8, respectively.  
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This analysis makes the important point that the smaller VGlut puncta continue to 
co-localize with post-synaptic markers, suggesting that the markers are tracking 




Table 14: Colocalization of synaptic markers following 7d 17αE2 
PSD95-VGlut1 
Coloc. 
Average+/- SEM n P value  
Contra cMD  0.57±0.04  6 one-way ANOVA, 
F(df,17)=18.67, p<0.001 
Contra 7d 17αE2 0.77±0.01 6 *=p<0.01 TK post hoc 
Contra 7d 17αE2 
Stim 
0.79±0.02 6 *=p<0.01 TK post hoc 
Ipsi cMD  0.58±0.03  6 one-way ANOVA, 
F(df,17)=16.85, p<0.001 
Ipsi 7d 17αE2 0.73±0.02 6 *=p<0.01 TK post hoc 
Ipsi 7d 17αE2 Stim  0.77±0.02 6 *=p<0.01 TK post hoc 
pS831-VGlut1 
Coloc. 
Average+/- SEM n P value 
Contra cMD  0.42±0.05  6 one-way ANOVA, 
F(df,17)=9.86, p=0.002 
Contra 7d 17αE2 0.65±0.05 6 *=p<0.01 TK post hoc 
Contra 7d 17αE2 
Stim 
0.70±0.04 6 *=p<0.01 TK post hoc 
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Ipsi cMD  0.45±0.03  6 one-way ANOVA, 
F(df,17)=7.30, p=0.006 
Ipsi 7d 17αE2 0.58±0.07 6 *=p<0.01 TK post hoc 
Ipsi 7d 17αE2 Stim 0.70±0.04 6 *=p<0.01 TK post hoc 
PSD95-VGlut2 
Coloc. 
Average+/- SEM n P value 
Contra cMD  0.45±0.03 4 one-way ANOVA, 
F(df,13)=0.64, p=0.54 
Contra 7d 17αE2 0.41±0.01 4 NS, p>0.05 
Contra 7d 17αE2 
Stim 
0.47±0.05 4 NS, p>0.05 
Ipsi cMD  0.45±0.02 6 one-way ANOVA, 
F(df,13)=0.59, p=0.57 
Ipsi 7d 17αE2 0.46±0.02 4 NS, p>0.05 
Ipsi 7d 17αE2 Stim 0.48±0.03 4 NS, p>0.05 
pS831-VGlut2 
Coloc. 
Average+/- SEM n P value 
Contra cMD  0.37±0.03 6 one-way ANOVA, 
F(df,17)=23.86, p<0.001 
Contra 7d 17αE2 0.56±0.01 4 *=p<0.01 TK post hoc 
Contra 7d 17αE2 
Stim 
0.60±0.02 4 *=p<0.01 TK post hoc 
Ipsi cMD  0.38±0.03  6 one-way ANOVA, 
F(df,17)=26.51, p<0.0001 
Ipsi 7d 17αE2 0.59±0.01  4 *=p<0.01 TK post hoc 
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Ipsi 7d 17αE2 Stim 0.60±0.03 4 *=p<0.01 TK post hoc 
pS831-PSD95 
Coloc. 
Average+/- SEM n P value 
Contra cMD  0.48±0.02 6 one-way ANOVA, 
F(df,13)=0.28, p=0.76 
Contra 7d 17αE2 0.45±0.01 4 NS, p>0.05 
Contra 7d 17αE2 
Stim 
0.46±0.05 4 NS, p>0.05 
Ipsi cMD  0.50±0.02 6 one-way ANOVA, 
F(df,13)=0.38, p=0.69 
Ipsi 7d 17αE2 0.49±0.03 4 NS, p>0.05 












Figure 20. Colocalization of cortico-cortical marker increased following 7 days of 17αE2 
A. VGlut1-PSD95 Pearson’s Correlation Coefficient (PCC) in cMD V1b is significantly 
increased following both 7 days 17αE2 paradigms in V1b contralateral (left) and ipsilateral 
(right) to the occluded eye. Contralateral V1b: one-way ANOVA, F(df,17)=18.67, p<0.001, 
*=p<0.01 Tukey-Kramer post hoc; Ipsilateral V1b: one-way ANOVA, F(df,17)=16.85, 
p<0.001,*=p<0.01 Tukey-Kramer post hoc, n= 6. B. VGlut1-pS831 PCC in contralateral cMD 
V1b is significantly increased following 7 days 17αE2 +/- visual, but only increased 
significantly after 7 days 17αE2 followed by visual stimulation in ipsilateral cMD V1b. 
Contralateral V1b: one-way ANOVA, F(df,17)=9.86, p=0.002, *=p<0.01 Tukey-Kramer post 
hoc ; Ipsilateral V1b: one-way ANOVA, F(df,17)=7.30, p=0.006, *=p<0.01 Tukey-Kramer post 





3.4.13 Assessing the effect of 17αE2 administration on Stimulus-Selective 
Response Potentiation  
 
One way to assess the functional impact of the 17αE2-induced changes in 
V1 of cMD subjects is to probe the response to repetitive visual stimulation (Sam 
F Cooke & Bear, 2010; Furmanski et al., 2004; Teyler et al., 2005). Repeated 
presentation of a visual stimuli has been shown in humans and other species to 
induce a potentiation of the amplitude of the physiologically recorded visual 
response. In fact, so called “photic LTP” induced by repetitive flash stimulation to 
rats was sufficient to induce rapid (15 minutes after onset of stimulus) 
Figure 21. Colocalization of thalamocortical marker with pS831 increased following 7 
days of 17αE2 
A. No change in VGlut2-PSD95 Pearson’s Correlation Coefficient (PCC) in cMD V1b following 
either paradigm in contralateral and ipsilateral hemispheres, n= 6, 4, 4, respectively. B. 
VGlut2-pS831 PCC is significantly increased in both hemispheres of cMD V1b following both 
paradigms. Contralateral V1b: one-way ANOVA, F(df,17)=23.86, p<0.001, *=p<0.01 Tukey-
Kramer post hoc; Ipsilateral V1b: one-way ANOVA, F(df,17)=26.51, p<0.0001, *=p<0.01 
Tukey-Kramer post hoc , n= 6, 4, 4, respectively. 
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potentiation of visually-evoked potentials (VEPs) that was comparable to theta 
burst stimulation applied directly to the LGN (Heynen & Bear, 2001). Repetitive 
visual stimulation (400 cycles / day of 0.05 cycles per degree (cpd), 100% 
contrast, full field gratings at 0.5 Hz) has also been shown to induce a slowly 
emerging, long-lasting, stimulus-specific response potentiation (SRP) of the V1 
VEP (Sam F Cooke & Bear, 2010; Frenkel et al., 2006). Importantly, SRP 
induction requires hundreds of repetitions of the visual stimulus, and the 
response potentiation is highly stimulus-selective, therefore observed in 
response to the familiar stimulus. Importantly, fewer presentations of the visual 
stimulus (100-200 cycles) do not induce this form of VEP potentiation, but 
manipulations that enhance plasticity in adult V1, such as dark exposure, 
promote SRP in response to this subthreshold induction protocol (Montey et al., 
2013).  
 
Therefore, to ask if 17αE2 promotes SRP in V1, I presented the 
subthreshold visual stimulus binocularly (200 x 1 second trials of square-wave 
gratings (0.05 cpd, 100% contrast, full-field 45 degree gratings reversing at 1 
Hz)). 24 hours later we measured the amplitude of visually-evoked potentials 
recorded from Layer 4 (~ 500 microns from the dura surface) of anesthetized 
(2.5% isoflurane in 100% O2) subjects in response to the familiar and a novel 
visual stimulus. As expected, in control subjects, the visual stimulation protocol 
did not induce SRP, as the VEP amplitude was similar in response to the familiar 
and novel stimuli presented to either the previously deprived or previously non-
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deprived eye (µV, AVG±SEM; non-deprived eye; familiar: 22.37±1.28, novel: 
22.71±2.55, n=4; deprived; familiar: 21.65±3.59, novel: 19.99±3.359, n=4, Fig. 
22B&C). However, 17αE2 treatment prior to visual stimulation resulted in a 
significant SRP in the VEP evoked from the non-deprived eye, as VEP 
amplitudes were significantly increased in response to the familiar but not novel 
stimulus (µV, AVG±SEM; familiar: 36.10±6.38, novel: 27.11±4.93, n=6 subjects, 
two-tailed paired t-test, p = 0.024, t=2. 570, Fig. 22C). No SRP was observed in 
the amplitude of the VEP evoked from the previously deprived eye (µV, 
AVG±SEM; familiar: 25.56±4.49, novel: 29.154±3.80, n=6 subjects, Fig. 22C). 
Together this demonstrates that experience-dependent plasticity can be 
enhanced by 17αE2 in amblyopic V1, but the enhancement is specific to the 






Figure 22. 17αE2 promotes SRP specifically in non-deprived eye responses  
A. Experimental timeline. Subjects receive monocular deprivation from eye opening 
(~P14) to adulthood (>P180) and receive 17αE2 (15 μg/kg, s.c.) 30 minutes prior to 
eye opening and binocular visual stimulation (200 phase reversal of high contrast 
grating at a single orientation). VEPs in response to flash, and familiar and novel 
stimulus orientations are assessed after 24 hours. B. Increase in average VEP 
amplitude in response to familiar (dark red) versus novel (light red) stimuli presented 
to ipsilateral eye following 17αE2 treatment. Inset: representative VEP waveforms in 
response to the familiar stimulus, scale 0.1s, 10 μV. *p<0.05, two-way paired t-test, 
17αE2+Stim n=6, 17αE2 n = 5, Stim n=4. C. No increase in average VEP amplitude 
in response to familiar (dark blue) stimulus presented to contralateral eye following 
17αE2 treatment. Inset: Representative VEP waveforms in response to the familiar 




3.4.14. Markers for constrained plasticity are differentially regulated 
following 17αE2 administration and SRP stimulation protocol  
 
Unfortunately, the SRP experiment does not provide an additional timepoint 
(24 hours post 17αE2 delivery) to my investigation of the regulation of plasticity 
by 17αE2, as all of the subjects in this cohort received visual stimulation to record 
visually evoked potentials. However, this allows me to ask how the SRP-inducing 
visual stimulation impacts cortical markers for plasticity and synapses. 24 hours 
after 17αE2 and visual stimulus, I observed a significant increase in the 
expression of PV and a significant decrease in WFA in both hemispheres 
(AVG±SEM; PV: Contra cMD 26.18±2.67 vs. Contra 17αE2 24hr 42.23±4.38, 
p<0.001; vs. Contra 17αE2 24hr Stim 42.70±3.00, p<0.001; Ipsi cMD 25.59±1.42 
vs. Ipsi 17αE2 24hr 48.38±6.32, p<0.001; vs. Ipsi 17αE2 24hr Stim 37.90±2.07; 
WFA: Contra cMD 16.63±2.08 vs. Contra 17αE2 24hr 10.70±1.77, p<0.001; vs. 
Contra 17αE2 24hr Stim 12.13±1.51, p<0.001; Ipsi cMD 18.23±2.79 vs. Ipsi 
17αE2 24hr 11.83±2.15; *=p<0.001, vs. Ipsi 17αE2 24hr Stim 10.38±1.03; 
p<0.001, K-S Test, n=6, 5, 6, respectively, Fig.23C). This is an interesting result, 
consistent with the observation that PV activity is necessary for the induction of 
SRP (Kaplan et al., 2016), as 17αE2 followed by visual stimulus induces an early 










3.4.15. 17αE2 administration followed by SRP stimulation protocol 
increases markers for excitatory synapses 
 
As expected, 24 hours after 17αE2 plus visual stimulation, I observed a 
significant increase in the size and number of PSD95 and pS831 immunoreactive 
puncta (Table 15-16, Fig.24) in V1b contralateral and ipsilateral to the occluded 
eye (Table 15-16, Fig.24) as well as an increase in the size, but not number, of 
VGlut2 puncta (Table 17, Fig.25B). It is tempting to speculate that the increase in 
PSD95, pS831, and VGlut2 represent the stimulus-selective response 







Figure 23: 17αE2 before SRP protocol reduces PV and WFA staining in cMD V1b 
A. Experimental timeline. Subjects receive cMD and 17αE2 (15 μg/kg, s.c.) 30 minutes prior to 
eye opening, a subset received binocular visual stimulation (200 phase reversal of high 
contrast grating at a single orientation). VEPs in response to flash, and familiar and novel 
stimulus orientations are assessed after 24 hours .B. Top Left: Fluorescent micrographs of PV 
distribution in V1b (red, V1; ML: 4 mm AP: -6.72 mm DV: 1.5mm; ROI: 900 μm x 500 μm; 10x 
mag; MIP). Bottom Left: Graphic representations of impact of PV expression on pyramidal 
neuron excitability. Right: 17αE2 with or without visual stimulus and followed by the SRP 
protocol 24 hours later significantly increases PV intensity in V1b contralateral and ipsilateral 
to cMD, *=p<0.001, K-S Test, n=6, 5, 6, respectively. C. Top Left: Fluorescent micrographs of 
WFA distribution in V1b (green, V1; ML: 4mm AP: -6.72 mm DV: 1.5mm; ROI: 900 μm x 500 
μm; 10x mag; MIP). Bottom Left: Graphic representation of impact of WFA expression on 
plasticity. Right: : 17αE2 with or without visual stimulus and followed by the SRP protocol 24 
hours later significantly decreases WFA intensity in V1b contralateral and ipsilateral to cMD, 
*=p<0.001, K-S Test, n=6, 5, 6.  
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Table 15: PSD95 size / number following 17αE2 24hrs  
PSD95 Puncta Size Average+/- SEM n P value  
Contra cMD  0.080±0.01 μm2 6 KS test 
Contra 17αE2 24hr 0.111±0.009 μm2 5 *=p<0.001 v. Contra MD 
Contra 17αE2 24hr 
Stim 
0.136±0.008 μm2 6 *=p<0.001 v. Contra MD 
Ipsi cMD  0.078±0.01 μm2 6 KS test 
Ipsi 17αE2 24h 0.0121±0.008 μm2 5 *p<0.001 v. Ipsi MD 
Ipsi 17αE2 24hr Stim  0.133±0.008 μm2 6 *p<0.001 v. Ipsi MD 
PSD95 Puncta # Average+/- SEM n P value 
Contra cMD  250.97±29.30 6 one-way ANOVA, F(df,16) 
=8.05, p=0.005, 
Contra 17αE2 24hr 381.58±48.68 5 *=p<0.01 TK post hoc 
Contra 17αE2 24hr 
Stim 
473.85±53.43 6 *=p<0.01 TK post hoc 
Ipsi cMD  235.60±35.44 6 one-way ANOVA, F(df,16) 
=1.81 p=0.199 
Ipsi 17αE2 24h 341.43±51.72 5 NS, p>0.05 







Table 16: pS831 size / number following 17αE2 24hrs 
pS831 Puncta Size Average+/- SEM n P value  
Contra cMD  0.073±0.002 μm2 6 KS test 
Contra 17αE2 24hr 0.109±0.004μm2 5 *=p<0.001 v. Contra MD 
Contra 17αE2 24hr 
Stim 
0.145±0.04μm2 6 *=p<0.001 v. Contra MD 
Ipsi cMD  0.069±0.005 μm2 6 KS test 
Ipsi 17αE2 24h 0.070±0.003 μm2 5 *p<0.001 v. Ipsi MD 
Ipsi 17αE2 24hr 
Stim  
0.101±0.004 μm2 6 *p<0.001 v. Ipsi MD 
pS831 Puncta # Average+/- SEM n P value 
Contra cMD  234.74±49.94 6  one-way ANOVA, F(df,16) 
=19.66, p<0.0001 
Contra 17αE2 24hr 725.62±71.32 5 *=p<0.01 TK post hoc 
Contra 17αE2 24hr 
Stim 
650.92±75.28 6 *=p<0.01 TK post hoc 
Ipsi cMD  240.40±64.77 6 one-way ANOVA, F(df,16) 
=17.75, p=0.0001 
Ipsi 17αE2 24h 494.73±75.72 5 *=p<0.01 TK post hoc 
Ipsi 17αE2 24hr 
Stim  
























Figure 24. 17αE2 prior to SRP protocol increases markers for excitatory synapses and 
activity 
A. Left: Experimental timeline. Subjects receive cMD and then 17αE2 (15 μg/kg, s.c.) 30 
minutes prior to eye opening, a subset received binocular visual stimulation (200 phase 
reversal of high contrast grating at a single orientation). VEPs in response to flash, and 
familiar and novel stimulus orientations are assessed after 24 hours. Right: Fluorescent 
micrograph ROI location in Layer 4 of V1b (red box). B. Top: Fluorescent micrographs of 
PSD95 immunoreactivity (yellow) in V1b contralateral (left) and ipsilateral (right) to the cMD 
eye and after 17αE2 +/-  visual stimulation and followed by the SRP protocol, (ML: 4mm AP: -
6.72 mm DV: 1.5mm; ~500 μm from surface; ROI: 28.34 μm x 28.34 μm x 40 μm, 100x mag 
with 3x digital zoom; MIP). Bottom: Cumulative distribution of PSD95 immunoreactive puncta 
size (yellow) reveals significant increase in V1b contralateral (left) and ipsilateral (right) to the 
occluded eye with 17αE2 +/- visual stimulation prior to the SRP protocol, *=p<0.001, K-S Test. 
PSD95 puncta number was significantly increased in V1b contralateral to the occluded eye in 
subjects that received 17αE2 and visual stimulus prior to SRP assessment; one-way ANOVA, 
F(df,16)=8.05, p=0.005, *=p<0.01 T-K post hoc, n=6, 5, 6, respectively. C. Top: Fluorescent 
micrographs of pS831 immunoreactivity (green) in V1b contralateral (left) and ipsilateral (right) 
to the cMD eye and after 17αE2 +/- visual stimulation and followed by the SRP protocol, (V1; 
ML: 4mm AP: -6.72 mm DV: 1.5mm; ~500 μm from surface; ROI: 28.34 μm x 28.34 μm x 40 
μm, 100x mag with 3x digital zoom; MIP). Bottom: Cumulative distribution of pS831 
immunoreactive puncta reveals significant increase in size V1b contralateral (left) and 
ipsilateral (right) to the cMD eye following both 17αE2+/- visual stimulation prior to the SRP 
protocol, *=p<0.001, K-S Test. pS831 puncta count is significantly increased following both 
paradigms in V1b contralateral (left) and ipsilateral (right) to the occluded eye. Contralateral 
V1b: one-way ANOVA, F(df,16)=19.66, p<0.0001, *=p<0.01 T-K post hoc; Ipsilateral V1b: 









Figure 25. 17αE2 before SRP protocol  increases size of  thalamocortical afferent 
markers  
A. Left: Experimental timeline. Subjects receive monocular deprivation from eye opening 
(~P14) to adulthood (>P180) and 7 days receive 17αE2 (15 μg/kg, s.c., 1x/day for 7 days) and 
visual stimulus (200 phase reversal of high contrast grating at a single orientation) following 
last day of 17αE2 treatment. Right: Fluorescent micrograph ROI location in Layer 4 of V1b 
(red box). B. Top: Fluorescent micrographs of VGlut2 immunoreactivity (magenta) in V1b 
contralateral (left) and ipsilateral (right) to the cMD eye and after 17αE2 with or without visual 
stimulus and followed by the SRP protocol 24 hours later, (V1; ML: 4mm AP: -6.72 mm DV: 
1.5mm; ~500 μm from surface; ROI: 28.34 μm x 28.34 μm x 40 μm, 100x mag with 3x digital 
zoom; MIP). Bottom: Cumulative distribution of VGlut2 immunoreactive puncta reveals 
significant increase in V1b contralateral (left) and ipsilateral (right) to the cMD eye following 
both 17αE2 and 17αE2 and visual stimulus prior to the SRP assessment protocol, *=p<0.001, 
K-S Test. VGlut2 puncta count is unchanged in V1b contralateral (left) and ipsilateral (right) to 






Table 17: VGlut2 size / number following 17αE2 24hrs 
VGlut2 Puncta 
Size 
Average+/- SEM n P value  
Contra cMD  18±0.01 μm2 6 KS test 
Contra 17αE2 24hr 0.13±0.01 μm2 5 *=p<0.001 v. Contra MD 
Contra 17αE2 24hr 
Stim 
0.304±0.03μm2 6 *=p<0.001 v. Contra MD 
Ipsi cMD  0.17±0.02 μm2 6 KS test 
Ipsi 17αE2 24h 0.300±0.009μm2 5 *p<0.001 v. Ipsi MD 
Ipsi 17αE2 24hr 
Stim  
0.300±0.009μm2 6 *p<0.001 v. Ipsi MD 
VGlut2 Puncta # Average+/- SEM n P value 
Contra cMD  373.69±26.56 6 one-way ANOVA, F(df,16) 
=0.86, p=0.44 
Contra 17αE2 24hr 352.82±23.67 5 NS, p>0.05 
Contra 17αE2 24hr 
Stim 
334.24±21.33 6 NS, p>0.05 
Ipsi cMD  287.69±49.28 6 one-way ANOVA, F(df,16) 
=1.11, p=0.35 
Ipsi 17αE2 24h 348.17±27.00 5 NS, p>0.05 
Ipsi 17αE2 24hr 
Stim  




Finally, 17αE2 administration and subsequent SRP induction paradigm did 
not affect the colocalization between pre- and post-synaptic markers (Table 18).  
 
Table 18: Colocalization of synaptic markers following size / number 
following 17αE2 24hrs 
PSD95-VGlut2 
Coloc. 
Average+/- SEM n P value 




0.41±0.02 5 NS, p>0.05 
Contra 17αE2 
24hrs Stim 
0.47±0.04 6 NS, p>0.05 
Ipsi cMD  0.45±0.02 6 one-way ANOVA, F(df,16) 
=3.04, p=0.08 
Ipsi 17αE2 24hrs 0.38±0.02 5 NS, p>0.05 
Ipsi 17αE2 24hrs 
Stim  
0.47±0.03 6 NS, p>0.05 
pS831-VGlut2 
Coloc. 
Average+/- SEM n P value 









0.43±0.04 6 NS, p>0.05 
Ipsi cMD  0.38±0.03  6 one-way ANOVA, F(df,16) 
=0.57, p=0.58 
Ipsi 17αE2 24hrs 0.36±0.01 5 NS, p>0.05 
Ipsi 17αE2 24hrs 
Stim  
0.40±0.03 6 NS, p>0.05 
pS831-PSD95 
Coloc. 
Average+/- SEM n P value 




0.44±0.02 5 NS, p>0.05 
Contra 17αE2 
24hrs Stim 
0.47±0.05 6 NS, p>0.05 
Ipsi cMD  0.50±0.02 6 one-way ANOVA, F(df,16) 
=1.49, p=0.25 
Ipsi 17αE2 24hrs 0.43±0.02 5 NS, p>0.05 
Ipsi 17αE2 24hrs 
Stim  








ERs persist in the visual cortex of aged males and females, and therefore 
offer a potential opportunity for the use of estrogen to promote plasticity. Using 
fixed-tissue immunohistochemistry and electrophysiology I asked if estrogen, 
employed in either in a single, physiologically-relevant dose or a week-long 
course, can reverse the anatomical and functional deficits of cMD. I found that 
17αE2 treatment induces changes in the cortex that are indicative of enhanced 
plasticity in deprived and non-deprived V1, and these changes are amplified 
when 17αE2 is followed by visual stimulation. Importantly, 17αE2 treatment 
promoted plasticity in the amblyopic visual cortex, but stimulus-selective 
response potentiation was observed only in the pathway served by the deprived 
eye. This suggests that the selectivity of estrogen may be used to enhance 
receptive field plasticity at intact, non-injured synapses, such as those that 
surround a cortical infract or scotoma. Although the current experiments cannot 
distinguish between individual synapses that are dominated by input from the 
deprived versus non-deprived eye, one possibility is that increase in the 
excitatory synaptic markers that increase in size serve the non-deprived eye.  
 
The presence of ERs in adult rodent V1 has been controversial (Jeong et 
al., 2011; Mitra et al., 2003; Shughrue & Merchenthaler, 2001), it was therefore 
important to first demonstrate the expression of ERs in rodent V1, identify the 
subtypes expressed and to ask if there are differences in the expression between 
intact males and females. I confirmed a heretofore uncorroborated report of 
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expression of both classical estrogen receptor subtypes in rodent visual cortex 
(Jeong et al., 2011), and demonstrated that these receptors do not co-localize 
with a nuclear marker.  This is consistent with  previous reports of extranuclear 
ERs in hippocampus (Milner et al., 2001; Milner et al., 2005), prefrontal cortex, 
and dorsal striatum (Almey et al., 2016), regions of the brain shown to express 
rapid, estrogen-dependent synaptic plasticity.  17αE2 enhancement of synaptic 
plasticity includes potentiation of synaptic responses, increases in spine density, 
or improvement of behavioral performance. Importantly, these effects of estrogen 
are observed rapidly, between 30 minutes to 2 hours (Kramár et al., 2013; 
Kramár et al., 2009; Luine et al., 2003; MacLusky et al., 2005), and locally 
activate kinase pathways at the synapse. Although synaptic signaling is distinct 
from transcriptional affects (Dominguez & Micevych, 2010; Lai et al., 2017; 
Srivastava et al., 2010), the two pathways may act cooperatively to express 
plasticity (Titolo et al., 2008). Most experiments detailed in this dissertation are 
performed on a similar timescale (~2.5 hours). However, I cannot rule out a 
transcriptional response, as transcriptional mechanisms can be engaged by 2 
hours to engage after steroid hormone treatment (Marino et al., 2006).     
 
Although the majority of estrogen replacement work examines the effect of 
17β treatment, I chose to use the 17α isomer of estradiol. Previous electron 
microscopic examination of rat hippocampal CA1 revealed a significant increase 
in pyramidal  neuron spiny synapses 30 minutes after peripheral administration of 
17α 17αE2 treatment (MacLusky et al., 2005).  17α 17αE2 also increased 
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performance in novel object recognition tasks when 17αE2 was given during 
sample acquisition trials (Luine et al., 2003). In addition, 17α 17αE2 has been 
shown to induce less off-target effects, an observation that I confirmed by 
demonstrating no change in gonadal wet weight after a 7 day course of 17αE2. 
Since certain dosages and types of estrogens used in hormone therapy in 
humans have been shown to be oncogenic, I chose to use the isoform that had 
potentially lower risk (Dietel et al., 2005). 
 
Many changes in synaptic, neuronal and circuit structure occur with age 
and contribute to reduced plasticity. A dense ECM and strong inhibition from PV+ 
and other interneurons subtypes has been repeatedly associated with aging and 
an environment that is not permissive for synaptic plasticity (Hensch et al., 1998; 
Lensjø et al., 2017). Indeed, the maturation of GABA-ergic inhibition has been 
shown to terminate the critical period for ocular dominance plasticity (Fagiolini & 
Hensch, 2000; Kuhlman et al., 2013). Furthermore, PNNs, robust ECM 
specializations which surround mature PV+ interneurons and are associated with 
enhanced excitability (Balmer, 2016), further restrict structural and functional 
plasticity (Ye & Miao, 2013). Accordingly, reduction of inhibition, either through 
pharmacological or genetic methods (Bochner et al., 2014; Gu et al., 2016; 
Morishita et al., 2010), can reactivate plasticity in adults. Similarly, proteolytic 
digestion of the ECM reactivates juvenile-like plasticity in the adult visual cortex 
(Pizzorusso et al., 2002, 2006). Furthermore, dark exposure (DE), a non-invasive 
method to reactivates ocular dominance plasticity in adults, reduces GABA-ergic 
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inhibition (He et al., 2006; S. Huang et al., 2015). DE followed by light re-
exposure (LRx) induces a significant reduction in the density of the extracellular 
matrix (Murase et al., 2017). 17αE2 administration to cMD subjects induced a 
reduction in markers for both PV and ECM contralateral and ipsilateral to the 
occluded eye, which was enhanced in the contralateral hemisphere when 17αE2 
was followed by visual stimulation. This suggests a permissive environment 
synaptic activity may further promote synaptic plasticity. Interestingly, when 
17αE2 was followed by the SRP protocol, WFA levels remained low but PV 
expression increased, consistent with the idea that repetitive visual stimulation 
increases excitation onto PV neurons. The SRP-induced increase in PV 
expression may contribute to the stability of SRP, and has previously been 
shown to be important in SRP induction (Kaplan et al., 2016).  
 
 I found that 17αE2 treatment alone increases the size , but not number of 
PSD95 in V1b contralateral to the occluded eye,  and increases colocalization of 
pS831 and VGlut2, suggesting the 17αE2 may increase activity at 
thalamocortical synapses This is consistent with reports that PSD95 number 
does not change with 17αE2 in hippocampal slices from intact male or female 
rodents (W. Wang et al., 2016). 17αE2 alone can also enhance synaptic 
strength, which contributes to the promotion of LTP (Córdoba Montoya & Carrer, 
1997; Kramár et al., 2009; Oberlander & Woolley, 2016).  Consistent with a ‘two-
step wiring plasticity’ hypothesis (Srivastava, 2012), transient synapses induced 
by hormone administration are silent (NMDAR-only) and require activity-
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dependent AMPAR incorporation to stabilize newly-formed synapses (Srivastava 
et al., 2008). In support of this hypothesis, I showed that the effects of 17αE2 on 
PSD95 and pS831 are augmented by visual stimulation. 7 days of 17αE2 did not 
appear to confer any additional benefit to synaptic size or activity over a single 
dose. The 17αE2-induced decrease in VGlut1 and VGlut2 was counter-intuitive, 
as activity-dependent changes in postsynaptic size are often accompanied by a 
similar increase in size of the pre-synaptic specialization (Futai et al., 2007).  
However, these reductions could be indicative of decreased glutamate re-uptake 
in response to the administration of the hormone, which can also be regulated by 
membrane ERα (Sato et al., 2003). 
 
Finally, the SRP results revealed an unexpected specificity to the effects 
of 17αE2 on plasticity in cMD V1. Brief MD has been shown to increase the 
probability of release at synapses innervated by the deprived eye (Krahe & 
Guido, 2011; Yashiro et al., 2005). Similarly, we demonstrated a more rapid 
depression of the response to repetitive flash stimuli to the deprived eye than 
non-deprived eye, suggesting that cMD regulates the probability of 
neurotransmitter release. Importantly, estrogen administration can increase 
probability of release at excitatory synapses which have low initial probability 
release (Smejkalova & Woolley, 2010). 17αE2 promoted plasticity in the adult 
amblyopic cortex, but the stimulus-dependent increase in VEP amplitude was 
observed only in the VEP evoked in the non-deprived eye. I propose that a MD-
induced increase in release probability in synapses serving the deprived eye, 
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suggested by the more rapid depression to repetitive visual stimulation, limited 
SRP to the synapses serving the non-deprived eye which have an initially low 
release probability. It would be interesting to see if visual stimulation could be 
used to drive down release probability in the deprived eye pathway to increase 
the sensitivity to estrogen-induced modulation. 
The expression of SRP after 17αE2 at 24 hours in cMD subjects may be 
reflected in the increase in markers of excitatory synapses relative to the 2 hour 
time point. As an increase in synaptic size is also indicative of an increase in 
synaptic strength (Ehrlich et al., 2007; Zhang & Lisman, 2012), a larger PSD95 
following 17αE2 would also support the potentiation of the VEP.  Additional 
controls must be performed to distinguish between these two possibilities, 
including 24 hours after 17αE2 alone and 24 hours after SRP induction protocol 
alone. Nonetheless, these results demonstrate that the aged V1 retains 
sensitivity to enhancement plasticity by estrogen, which may be therapeutically 
beneficial in promoting plasticity of spared inputs around a scotoma to recover a 




Chapter 4 : Implications of Results & Future Directions for research 
 
4.1 Discussion of Results  
 
4.1.1 Novel observations regarding the anatomical consequences of cMD in 
aged V1  
 
Although the amblyopia induced by cMD is resistant to recovery in adults, 
manipulations that increase plasticity in amblyopic V1b promote the recovery of 
visual function (Bochner et al., 2014; Pizzorusso et al., 2002; Sale et al., 2007; 
Vetencourt et al., 2008). Indeed, we have previously shown that deprived eye 
acuity fully recovers when the enhancement of cortical plasticity by dark 
exposure is followed by visual training (Eaton et al., 2016). One contribution of 
this work is the extension of the characterization of the impact of cMD on V1b in 
adult rodents to excitability of PV expressing interneurons, extracellular matrix 
density, excitatory synapse size and number, and regulation of presynaptic 
release probability. PV interneuron maturation is developmentally regulated, with 
a large body of evidence supporting an essential role in the onset and closure of 
critical period plasticity (Beurdeley et al., 2012; Hensch, 2005; Kuhlman et al., 
2013; Levelt & Hübener, 2012).  Brief MD during the critical period induces a 
rapid decrease in the excitability of PV INs, which is reflected in decreased 
parvalbumin expression (Cellerino et al., 1992). In contrast, when MD is 
prolonged, PV expression returns to control levels (Mainardi et al., 2009). My 
work utilizing cMD revealed an increase in overall PV intensity in both ipsilateral 
and contralateral V1b of cMD subjects, suggesting a homeostatic response to 
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prolonged MD. Suppression of PV IN output can re-engage the critical period for 
ocular dominance plasticity (Kuhlman et al., 2013), but suppression of PV 
interneurons after MD does not (Kaplan et al., 2016). PV-expressing interneurons 
are preferentially surrounded by dense extracellular matrix, that is increased by 
cMD. The increase in PV expression and ECM density following cMD V1b is 
expected to contribute to the constraint in reversing the effects of cMD in adults, 
and identifies potential targets for therapies to reintroduce plasticity and recovery 
of visual function. 
  
We have previously reported that cMD induces a significant reduction in 
dendritic spine density in all cortical layers of V1b, including those that receive 
thalamic innervation (Montey & Quinlan, 2011). My own data utilizing viral 
transneuronal tracers demonstrates a reduction in innervation from the deprived 
eye to V1b. However, the number of PSD95 puncta and VGlut1/VGlut2 puncta 
were unchanged by cMD. One possibility is that cMD induces a collapse of 
dendritic spines onto the dendritic shaft, with no change in the number of 
excitatory synapses. Accordingly, during hibernation of some rodent species, 
dendritic spines collapse onto the shaft, yet they maintain synaptive connectivity 
and can later re-emerge as spiny synapses (Kirov et al., 2004; Roelandse, 2004). 
Additionally, in pyramidal neuron culture, retraction of dendritic spines is 
independent of a loss of PSD95, and in some cases, spine retraction is 
associated with an increase in PSD95 fluorescence on the dendritic shaft 
(Woods et al., 2011). This interpretation is consistent with the observation that 
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despite cMD, visual stimulation of the chronically deprived eye continues to 
evoked weak responses in deprived V1 (Montey & Quinlan, 2011), as shaft 
synapses produce synaptic potentials that are many orders of magnitude smaller 
than those elicited from a spiny synapse (Gulledge et al., 2012; Kawato & 
Tsukahara, 1984). Another possibility is that following cMD, a loss of deprived 
eye synapses is masked by an increase in non-deprived eye synapses, or that 
excitatory synapses onto excitatory neurons are reduced, while excitatory 
synapses onto inhibitory neurons are increased. Indeed, my data also indicates 
that PV expression is increased following cMD, supporting the latter possibility.  
 
In addition, in vivo recordings revealed that the visual response evoked from 
the deprived eye depresses more quickly than the visual response evoked from 
the deprived eye, which is indicative of an increase probability of release. The 
increase in release probability likely reflects homeostatic plasticity employed to 
maintain synaptic activity in the face of prolonged sensory deprivation (Krahe & 
Guido, 2011; Maffei et al., 2004; Yashiro et al., 2005). This observation suggests 
that therapies to enhance synaptic function via regulation of presynaptic release 
probability, such as estrogen, will not be effective at synapses serving the 
deprived eye. 
 
4.1.2 Assessing the effects of estrogen and visual stimulation on V1 of cMD 
adult rats 
 
The primary focus of my thesis work was to determine the potential for the 
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enhancement of structural and functional plasticity by 17αE2 to promote recovery 
of visual function lost by cMD. The persistence of robust, non-genomic ER 
expression after menopause/estropause has been well documented in primates 
and rodents, especially in the hippocampus, hypothalamus, and frontal cortex 
(Sharma & Thakur, 2006; Waters et al., 2011; Wilson et al., 2002). Although the 
presence of ERs in primary sensory cortices has been controversial (Jeong et al., 
2011; Mitra et al., 2003; Shughrue & Merchenthaler, 2001), I demonstrate robust 
ERα and ERβ expression in V1b of aged rats. Importantly, these appear to be 
largely extranuclear, similar to previous reports of extranuclear receptors in 
hippocampus (Milner et al., 2005, 2001), which have been implicated in engaging 
rapid anatomical and physiological synaptic plasticity (Srivastava et al., 2011). 
 
I showed that a single dose of Ε2 induces robust changes in the molecular 
composition of cMD V1b. 17αE2 reduces the density of the ECM after cMD, 
similar to other interventions that enhance plasticity in adult V1 (Murase et al., 
2017; Sale et al., 2007). Indeed, proteolytic digestion of ECM enhances synaptic 
plasticity in rodent V1, amygdala, perirhinal cortex, and hippocampus (Carstens 
et al., 2016; Pizzorusso et al., 2002, 2006; Romberg et al., 2013). Aα single dose 
of 17αE2 to cMD subjects also reduces the expression of PV, a proxy for the 
excitability of FS INs which is inversely correlated with the excitability of 
pyramidal neurons (Donato et al., 2013; Murase et al., 2017).  Estrogen 
treatment of rat organotypic slice cultures has also been shown to reduce PV 
expression (Ross & Porter, 2002). This reduction in WFA and PV is even greater 
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if 17αE2 treatment is paired with visual stimulation. Interestingly, WFA 
expression was further reduced after SRP induction in 17αE2-treated subjects, 
similar to previous findings that visual experience after dark exposure increases 
digestion of the ECM (Murase et al., 2017). The increase in PV expression 
following SRP is consistent with previous reports that sustained visual stimulation 
increases the activity of PV INs (Atallah et al., 2012) and the observation that PV 
activity is essential for the expression of SRP (Kaplan et al., 2016). 
 
The hypothesis that estrogen would promote the recovery from cMD was 
based on previous reports that estrogen administration increases the number of 
dendritic spines and/or spiny excitatory synapses (Kramár et al., 2013; Woolley & 
McEwen, 1993). However, in the aged V1b, I found an increase in the size, 
rather than the number, of PSD95 puncta, which suggests and enlargement of 
pre-existing excitatory synapses. I obtained similar results with multiple 17αE2 
treatments, 17αE2 followed by visual stimulation, or 7 days of 17αE2 followed by 
visual stimulus. An increase in F-actin, without a change in PSD95 puncta 
number, is observed following brief estrogen exposure in hippocampal slices 
from young male and middle-aged OVX female rats (Kramár et al., 2009; Wang 
et al., 2016). Golgi stains of mouse hippocampal tissue also reveal an increase in 
the number of large, mushroom-type spines following estrogen treatment in OVX 
females (Li et al., 2004). Interestingly, I observed a significant increase in pS831 
size when a single dose of 17αE2 was followed by visual stimulus and after 7 
days of 17αE2, but not in response to a single acute does of 17αE2 alone. This 
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suggests that the 17αE2-induced increase in size of pre-existing excitatory 
synapses is independent of AMPAR trafficking through CaMKII/PKC 
phosphorylation of AMPAR-GluA1 with 17αE2 alone, consistent with previous 
work that GluA1-containing AMAPRs are not upregulated after estrogen 
administration (Ferri et al., 2014).  However, 17αE2 with visual stimulation or 
prolonged 17αE2 treatment activates CaMKII / PKC signaling, or promotes the 
incorporation of new synapses into functional circuits which can respond to 
changes in synaptic CaMKII / PKC (Srivastava, 2012).  Although longer duration 
estrogen treatment regulates the expression of ERα/ERβ (Gréco et al., 2001), in 
vivo two-photon imaging of young adult OVX thy1-GFP mouse sensory cortex 
reveals more estrogen-induced spine formation following acute than chronic 
estrogen (Wang et al., 2018).    
 
 Curiously, the expression of the presynaptic glutamate transporters is 
reduced in response to estrogen treatment, despite previous reports that 
estrogen increases the expression of VGlut1 in cultured cortical neurons (Khan et 
al., 2013). However, estrogen has been shown to decrease glutamate re-uptake 
through an ERα- dependent mechanism, which may be mediated by a decrease 
in the expression of VGlut1 and VGlut2 (Sato et al., 2003).  My results 
demonstrate an exception to the observation that pre- and post-synaptic size are 
typically co-regulated (Futai et al., 2007).   
 
How do these 17αE2-induced changes in synaptic composition compare 
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to known effects of 17αE2 on synaptic function? Estrogen administration has 
been demonstrated to have wide-ranging effects on synaptic strength and 
plasticity, which can vary by brain region. 17αE2 fluctuations correlate with 
changes in the expression of LTP at excitatory synapses (Warren et al., 1995), 
increases in the amplitude and frequency of mEPSCs in rat hippocampal CA1 
pyramidal neurons in both sexes, and increases in glutamate uncaging-evoked 
EPSCs and calcium transients at a subset of dendritic spines (Oberlander & 
Woolley, 2016). Additionally, it has been reported that acute estrogen lowers the 
threshold and increases the magnitude of LTP induced by theta burst stimulation 
of excitatory synapses in the hippocampus of OVX rats (Córdoba Montoya & 
Carrer, 1997) and may induce a modest LTP-like strengthening of synapses 
alone (Kramár et al., 2013; Mukai et al., 2007). However, hormone replacement 
in OVX young mice increases mIPSC frequency and paired pulse depression at 
inhibitory synapses in frontal cortex, but not somatosensory cortex (Piekarski et 
al., 2017), indicating a difference in estrogen-induced action across brain 
regions.  
 
My experiments cannot determine if 17αE2 in cMD V1 is facilitating 
plasticity via ERα or ERβ, or the if receptors localized in the presynaptic or 
postsynaptic compartment mediate the observed effects. determination is 
complicated by the presence of both receptor subtypes in V1 of adult rodents, the 
presence of membrane-bound ERα and ERβ in excitatory and inhibitory neurons, 
and their localization in both the post- or presynaptic specializations of these 
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cells. However, my results are best explained by estrogen acting upon ERs at the 
presynaptic terminals of both inhibitory and excitatory neurons. Activation of 
presynaptic ERα reduces the strength of inhibitory synapses. In hippocampal 
neurons in culture, 24 hours of estrogen administration decreases mIPSCs, 
increases mEPSCs, and increases dendritic spine density (Murphy et al., 1998).  
Acute estrogen rapidly reduces mIPSC frequency in pyramidal neurons of layer 
2/3 V1 in older mice, and an ERα antagonist occludes the decrease in mIPSC 
amplitude observed following dark exposure (Gao et al., 2017). These results are 
consistent with estrogen reducing the strength of inhibitory transmission via 
presynaptic ERα and support my findings that 17αE2 administration decreases 
PV+ interneuron activity and reduces WFA staining for ECM, which may disinhibit 
excitatory pyramidal neurons. While 17α estradiol shows preferential activation of 
ERα over ERβ (Toran-Allerand et al., 2005), other findings of my work indicate 
involvement of presynaptic ERβ activation in excitatory neurons. Estrogen 
administration has been shown to potentiate glutamatergic synaptic transmission, 
via an ERβ-dependent mechanism, by increasing release probability specifically 
at synapses with initially low probability of release (Smejkalova & Woolley, 2010). 
This supports the specific enhancement of the non-deprived eye VEP in 
response to a familiar orientation (SRP), which was occluded in synapses with an 
increased probability of release due to cMD. Furthermore, post-synaptic 
activation of ERs on excitatory neurons is associated with formation of new spine 
synapses (Hojo et al., 2008; Kramár et al., 2009;  Srivastava & Woolfrey, 2010), 
which I did not observe following any 17αE2 administration paradigms. To test 
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these predictions, further experiments can utilize ERα or ERβ selective agonists; 
propyl pyrazole triol (PPT) for ERα and diarylpropionitrile (DPN) and WAY2700 
for ERβ, (Harrington et al., 2003). These compounds could be used in 
conjunction with receptor-specific antagonists, methyl-piperidinopyrazole (MPP) 
against ERα and R,R-tetrahydrochrysene (R,R-THC) against ERβ (Harrington et 
al., 2003), in rodent V1 to specifically activate the different receptor types and 
their downstream effectors. 
 
 
As stated previously, 17αE2 treatment of adult amblyopes enabled the 
induction of SRP of the visual responses evoked by non-deprived eye 
stimulation. Estrogen potentiation of EPSCs in hippocampus has been shown to 
occur selectively at synapses with an initially low probability of glutamate release 
(Smejkalova & Woolley, 2010). As VEPs acquired from the previously deprived 
eye depress more rapidly than the non-deprived eye in response to repetitive 
stimulation, a cMD-induced increase in release probability may occlude the 
enhancement of plasticity by estrogen at synapses serving the deprived eye. 
Deprived eye responses are also significantly weaker and less stimulus selective 
than non-deprived eye responses following cMD (Montey et al., 2013). However, 
these changes are not likely to explain the absence of SRP in the deprived eye 
pathway, as high contrast, low spatial frequency stimuli elicit visual responses 
through the deprived eye and can be enhanced by dark exposure (Montey et al., 
2013; Montey & Quinlan, 2011). Interestingly, the strengthening of non-deprived 
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eye synapses which is part of the normal response to cMD does not occlude the 
induction of SRP or the enhancement of plasticity by 17αE2, suggesting that the 
mechanisms engaged by these pathways are not saturated in amblyopic cortex. 
Moreover, these results suggest that the specificity of 17αE2 is defined by 
synaptic characteristics that reflect the history of synaptic activity. Importantly, 
the persistence of ERs in aged V1 and the enhancement of plasticity of synapses 
in the intact, non-deprived eye pathway opens up the possibility that 17αE2 could 
be combined with perceptual training to abate the loss of visual acuity with age. 
Therefore, selective enhancement of plasticity by 17αE2 at synapses with initially 
low release probability may also promote plasticity of spared inputs around a 
scotoma or a cortical infarct.  
 
4.2 Limitations of Experimental Approach 
 
 As with any experiment, there are limitations to the interpretations of the 
presented work. Methodologically, the use of markers for excitatory synapses in 
fixed tissue prevents the assessment of changes in spine density within a single 
neuron or individual over time, which could be revealed with a method like in vivo 
two photon imaging of GFP-filled dendrites. Additionally, the cohort sizes used in 
my studies did not allow me to analyze males and females separately. Increasing 
the number of subjects would permit the exploration of any sex-specific 
differences in the effects 17αE2 administration to cMD V1, as estrogen-induced 
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plasticity may act through distinct mechanisms in males and females (Oberlander 
& Woolley, 2016). 
 
Furthermore, we employed acute rather than chronic electrophysiology to 
examine the effects of cMD and 17αE2 administration to deprived visual cortex. 
This allowed for the assessment of the effects of cMD and 17αE2 on visual 
responses evoked by deprived and non-deprived eye stimulation, with minimal 
damage to V1b to allow for post mortem immunohistochemistry. However, 
repeated physiological recordings following chronic electrode implantation would 
have allowed for a more detailed time course of the effects of 17αE2, including 
the timing of the initial response, response longevity, and confirmation of the 
homeostatic changes predicted in Chapter 3.  
 
4.3 Recommendations for Future Research  
 
Our work revealed that estrogen enhancement of synaptic function may 
be limited to a subset of synapses with an initial low probability of release, and 
support previous reports in hippocampus (Smejkalova & Woolley, 2010). The 
cMD-induced increase in response probability may preclude the effects of 
estrogen at deprived eye synapses. This synapse specific targeting could be 
harnessed for therapeutically-relevant treatment of deficits other than amblyopia. 
Pathological scotoma, or visual blind spots, can be initiated by a retinal lesion 
(Baseler et al., 2009), optic nerve injury (Knight & Hoyt, 1972) or cortical damage 
due to lesion or infarct (Pula & Yuen, 2017; Rizzo & Robin, 1996). These deficits 
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sometimes spontaneously improve (Rizzo & Robin, 1996), and successful 
treatment paradigms using repetitive visual stimulation indicate that the locus of 
recovery from these deficits may occur in V1 (Zihl & Von Cramon, 1985). This 
mechanism may be ideal for enhancing plasticity at preserved inputs around 
injuries. Additionally, it has been demonstrated that reduction in presynaptic 
release probability suppresses low, but not high frequency synaptic transmission 
(Seeburg, 2004). Therefore, it may be useful to test the effect of 17αE2 on SRP 
induced in cMDs with visual stimuli of higher temporal frequencies. In addition, 
release probability could be experimentally manipulated to enhance sensitivity to 
estrogen. One interesting possibility would be to present experimental subjects 
with repetitive visual stimulation to the deprived eye, to drive down the initial 
probability of release, to ask if this enhances the sensitivity to subsequent 17αE2 
administration (Saviane et al., 2002).  
 
Ideally, I would have combined cytoplasmic fills of neurons to assess 
dendritic spines with immunohistochemical assessment of excitatory synapse 
components. This approach would have also allowed be to resolve the effect of 
the acute administration of 17αE2 in V1 on the diverse morphologies of dendritic 
spines (filopodial, thin, mushroom, stubby), as well as synaptic composition. 
However Golgi impregnation makes co-staining with other synaptic markers 
difficult (Gould et al., 1990; Li et al., 2004; Woolley & McEwen, 1993). In pilot 
experiments, I delivered an AAV2-GFP regulated by a CaMKII promoter 
intracortically to V1 of cMD subjects to induce sparse, whole neuron fluorescence 
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in pyramidal cells (Watakabe et al., 2015) . However, expression was too sparse 
in the aged cortex and did not provide any of the intended whole neuron, 
cytoplasmic fill, possibly due to increased extracellular matrix expression in these 
cMD subjects, as dense extracellular matrix around cancer cells prevents their 
infection by therapeutic AAV (Yata et al., 2015),  so I abandoned this technique. 
Therefore, another possibility would be to repeat these experiments in transgenic 
mice expressing Thy1-GFP, which have been have been used successfully in 
recent estrogen plasticity studies to examine the changes in cortical spine 
morphology in vivo over the course of naturally-occurring estrogen fluctuations 
(Alexander et al., 2018) or following estrogen administration (S. Wang et al., 
2018). The addition of more time points and controls would strengthen the 
interpretation of some of these experiments. For example, PV and WFA staining 
are different 2 versus 24 hours after 17αE2 administration, but the 24 hour 
measurement was after SRP stimulation. Additional controls would include 24 
hours after 17αE2 alone 24 hours after SRP induction protocol alone. 
Furthermore, additional time course experiments could be used to determine the 
optimal delivery schedule for 17αE2, as well as determine the advantage of a 
continuous or discontinuous delivery of hormone, as there is ongoing 
investigation of the benefits and risks of each regimen type (Grant et al., 2015). 
Interestingly, non-continuous estrogen administration to rodents (1x/3 days) was 
more effective than daily administration(1x/3-4 days) in protecting against 





In another set of pilot experiments, I investigated the impact of the steroid 
corticosterone on synaptic plasticity on the cMD V1, which has been shown in 
hippocampal slice culture to induce spinogenesis within an hour of administration 
(Murakami et al., 2018). However, my results indicated that acute administration 
of corticosterone had an overall negative impact on synaptic density and size in 
V1 contralateral and ipsilateral to the occlusion. Future experiments could 
combine 17αE2 with another steroid hormone, as 17αE2 plus progesterone has 
been demonstrated to enhance hippocampal spine density (J.-R. Chen et al., 
2009; Gould et al., 1990) and object memory consolidation in rodents (Harburger 
et al., 2009), and improve executive function in non-human primates compared to 
placebo-administered controls (Voytko et al., 2009). I also examined the 
possibility of directing 17αE2 to the visual cortex using magnetic beads and an 
external magnetic field, but this method was abandoned as it causing 
inflammation and damage. Alternatively, infusion of 17αE2 directly into cortex 
would circumvent off-target effects, and has been employed successfully in other 
studies (Fan et al., 2010; Fernandez et al., 2008; Xiao et al., 2013). Direct 
infusion of estrogen into either hippocampal structures or striatum demonstrated 
region-specific, independent effects on place and response learning (Zurkovsky 
et al., 2007). 
 
Finally, the prediction that 17αE2 treatment may be useful to promote 
receptor field plasticity of spared inputs is exciting and testable. Hormone therapy 
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has demonstrated great potential for the improvement of brain function, and this 
body of research provides a foundation for advancement of relatively low-risk, 
high compliance acute hormone therapy for the reversal of previously intractable 
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